Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	T cell receptor binding	HLA-A HLA-B HLA-C HLA-G CD3E	6.25e-07	20	172	5	GO:0042608
GeneOntologyMolecularFunction	CD8 receptor binding	HLA-A HLA-B HLA-C HLA-G	6.48e-07	9	172	4	GO:0042610
GeneOntologyMolecularFunction	TAP complex binding	HLA-A HLA-B HLA-C HLA-G	6.48e-07	9	172	4	GO:0062061
GeneOntologyMolecularFunction	TAP1 binding	HLA-A HLA-B HLA-C HLA-G	1.07e-06	10	172	4	GO:0046978
GeneOntologyMolecularFunction	TAP2 binding	HLA-A HLA-B HLA-C HLA-G	1.07e-06	10	172	4	GO:0046979
GeneOntologyMolecularFunction	TAP binding	HLA-A HLA-B HLA-C HLA-G	1.07e-06	10	172	4	GO:0046977
GeneOntologyMolecularFunction	beta-2-microglobulin binding	HLA-A HLA-B HLA-C HLA-G	2.49e-06	12	172	4	GO:0030881
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYO5B MYO9A MYO10 MYO1B GPR88 DNAH1 STARD9 KIF14	8.42e-06	118	172	8	GO:0003774
GeneOntologyMolecularFunction	natural killer cell lectin-like receptor binding	HLA-A HLA-B HLA-C HLA-G	1.16e-05	17	172	4	GO:0046703
GeneOntologyMolecularFunction	14-3-3 protein binding	HLA-A HLA-B HLA-C HLA-G KLHL22	2.94e-05	42	172	5	GO:0071889
GeneOntologyMolecularFunction	MHC class I protein binding	HLA-A HLA-B HLA-C HLA-G	1.58e-04	32	172	4	GO:0042288
GeneOntologyMolecularFunction	complement binding	CR1 CFB PTX3 C3AR1	1.58e-04	32	172	4	GO:0001848
GeneOntologyMolecularFunction	aminoacyl-tRNA editing activity	VARS2 LARS2 AARSD1	2.13e-04	14	172	3	GO:0002161
GeneOntologyMolecularFunction	microfilament motor activity	MYO5B MYO9A MYO10 MYO1B	3.12e-04	38	172	4	GO:0000146
GeneOntologyMolecularFunction	actin filament binding	MYO5B MYO9A MYO10 SYNE1 SPTAN1 SPTB ESPNL MYO1B	8.06e-04	227	172	8	GO:0051015
GeneOntologyMolecularFunction	peptide antigen binding	HLA-A HLA-B HLA-C HLA-G	8.33e-04	49	172	4	GO:0042605
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent	HLA-A HLA-B HLA-C HLA-G	3.34e-07	8	174	4	GO:0002485
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent	HLA-A HLA-B HLA-C HLA-G	8.23e-06	16	174	4	GO:0002486
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway	HLA-A HLA-B HLA-C HLA-G	1.07e-05	17	174	4	GO:0002484
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class Ib	HLA-A HLA-B HLA-C HLA-G	1.07e-05	17	174	4	GO:0002476
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide antigen via MHC class Ib	HLA-A HLA-B HLA-C HLA-G	1.37e-05	18	174	4	GO:0002428
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous peptide antigen via MHC class I	HLA-A HLA-B HLA-C HLA-G	1.37e-05	18	174	4	GO:0042590
GeneOntologyBiologicalProcess	neuron projection development	CACNA1A ARHGEF28 HLA-A HLA-B HLA-C MYO5B MYO9A ATP8A2 SYNE1 HLA-G ARFGEF1 SPG11 PRAG1 CIT CREBBP DIP2A STRN CD3E PLXNC1 UNC5C ANAPC2 DOCK7 KNDC1 LHFPL5 ACP4 PAQR3	2.93e-05	1285	174	26	GO:0031175
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I	HLA-A HLA-B HLA-C HLA-G	3.82e-05	23	174	4	GO:0019885
GeneOntologyBiologicalProcess	detection of stimulus	OR2T33 HLA-A HLA-B OR4D10 ATP8A2 PKD1L1 OR2C3 OR5A2 GPR88 OR8G1 OR2T8 OR10G6 TAS2R42 LHFPL5 OR1G1 GNB1 OR6T1 GPR148	4.12e-05	722	174	18	GO:0051606
GeneOntologyBiologicalProcess	protection from natural killer cell mediated cytotoxicity	HLA-A HLA-B HLA-G	4.78e-05	9	174	3	GO:0042270
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen	HLA-A HLA-B HLA-C HLA-G	5.39e-05	25	174	4	GO:0002483
GeneOntologyBiologicalProcess	antigen processing and presentation via MHC class Ib	HLA-A HLA-B HLA-C HLA-G	5.39e-05	25	174	4	GO:0002475
GeneOntologyBiologicalProcess	negative regulation of lymphocyte mediated immunity	HLA-A HLA-B PARP3 HLA-G CR1 CD96	7.29e-05	83	174	6	GO:0002707
GeneOntologyBiologicalProcess	regulation of cell projection organization	CACNA1A HLA-A HLA-B HLA-C MYO5B MYO9A MYO10 ATP8A2 SYNE1 HLA-G PRAG1 CIT ABHD17B PLXNC1 ANAPC2 WRAP73 KNDC1 ACP4 PAQR3	1.30e-04	863	174	19	GO:0031344
GeneOntologyBiologicalProcess	negative regulation of cellular component organization	HLA-A HLA-B HLA-C SPTAN1 SPTB HLA-G ARFGEF1 ARHGEF18 PRAG1 CIT KLHL22 KIF14 ACP4 TMEM39A NME6 FER1L5 NLRC3 PAQR3 NR1H4	1.32e-04	864	174	19	GO:0051129
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous antigen	HLA-A HLA-B HLA-C HLA-G	1.46e-04	32	174	4	GO:0019883
GeneOntologyBiologicalProcess	aminoacyl-tRNA metabolism involved in translational fidelity	VARS2 LARS2 AARSD1	1.59e-04	13	174	3	GO:0106074
GeneOntologyBiologicalProcess	negative regulation of leukocyte mediated immunity	HLA-A HLA-B PARP3 HLA-G CR1 CD96	1.64e-04	96	174	6	GO:0002704
GeneOntologyBiologicalProcess	tolerance induction	HLA-B HLA-G CD3E C3AR1	2.09e-04	35	174	4	GO:0002507
GeneOntologyBiologicalProcess	regulation of neuron projection development	CACNA1A HLA-A HLA-B HLA-C MYO5B ATP8A2 SYNE1 HLA-G PRAG1 CIT PLXNC1 ANAPC2 KNDC1 ACP4 PAQR3	2.22e-04	612	174	15	GO:0010975
GeneOntologyBiologicalProcess	neuron development	CACNA1A ARHGEF28 HLA-A HLA-B HLA-C MYO5B MYO9A ATP8A2 SYNE1 HLA-G ARFGEF1 SPG11 PRAG1 CIT CREBBP DIP2A STRN CD3E PLXNC1 UNC5C ANAPC2 DOCK7 KNDC1 LHFPL5 ACP4 PAQR3	2.43e-04	1463	174	26	GO:0048666
GeneOntologyBiologicalProcess	regulation of T cell tolerance induction	HLA-B HLA-G CD3E	2.49e-04	15	174	3	GO:0002664
GeneOntologyBiologicalProcess	regulation of plasma membrane bounded cell projection organization	CACNA1A HLA-A HLA-B HLA-C MYO5B MYO10 ATP8A2 SYNE1 HLA-G PRAG1 CIT ABHD17B PLXNC1 ANAPC2 WRAP73 KNDC1 ACP4 PAQR3	2.99e-04	846	174	18	GO:0120035
GeneOntologyBiologicalProcess	T cell tolerance induction	HLA-B HLA-G CD3E	3.68e-04	17	174	3	GO:0002517
GeneOntologyBiologicalProcess	negative regulation of natural killer cell mediated immunity	HLA-A HLA-B HLA-G CD96	3.88e-04	41	174	4	GO:0002716
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide antigen via MHC class I	HLA-A HLA-B HLA-C HLA-G	3.88e-04	41	174	4	GO:0002474
GeneOntologyBiologicalProcess	negative regulation of innate immune response	HLA-A HLA-B HLA-G CR1 NLRC3 CD96	4.15e-04	114	174	6	GO:0045824
GeneOntologyBiologicalProcess	positive regulation of T cell mediated cytotoxicity	HLA-A HLA-B HLA-C HLA-G	4.26e-04	42	174	4	GO:0001916
GeneOntologyCellularComponent	MHC class Ib protein complex	HLA-A HLA-B HLA-C HLA-G	1.59e-07	7	174	4	GO:0032398
GeneOntologyCellularComponent	MHC class I protein complex	HLA-A HLA-B HLA-C HLA-G	9.37e-07	10	174	4	GO:0042612
GeneOntologyCellularComponent	MHC class I peptide loading complex	HLA-A HLA-B HLA-C HLA-G	4.35e-06	14	174	4	GO:0042824
GeneOntologyCellularComponent	cis-Golgi network membrane	HLA-A HLA-B HLA-C HLA-G	1.01e-05	17	174	4	GO:0033106
GeneOntologyCellularComponent	Golgi medial cisterna	HLA-A HLA-B HLA-C HLA-G	3.63e-05	23	174	4	GO:0005797
GeneOntologyCellularComponent	MHC protein complex	HLA-A HLA-B HLA-C HLA-G	6.01e-05	26	174	4	GO:0042611
GeneOntologyCellularComponent	lumenal side of endoplasmic reticulum membrane	HLA-A HLA-B HLA-C HLA-G	1.98e-04	35	174	4	GO:0098553
GeneOntologyCellularComponent	endoplasmic reticulum exit site	HLA-A HLA-B HLA-C HLA-G	4.06e-04	42	174	4	GO:0070971
GeneOntologyCellularComponent	lysosomal membrane	ANKFY1 HLA-A HLA-B HLA-C HLA-G SPG11 NCSTN SLC39A8 CSF3R C3AR1 GNB1 GNB2	5.10e-04	462	174	12	GO:0005765
GeneOntologyCellularComponent	lytic vacuole membrane	ANKFY1 HLA-A HLA-B HLA-C HLA-G SPG11 NCSTN SLC39A8 CSF3R C3AR1 GNB1 GNB2	5.10e-04	462	174	12	GO:0098852
GeneOntologyCellularComponent	phagocytic vesicle membrane	HLA-A HLA-B HLA-C HLA-G CLEC4E	6.49e-04	83	174	5	GO:0030670
GeneOntologyCellularComponent	lumenal side of membrane	HLA-A HLA-B HLA-C HLA-G	6.78e-04	48	174	4	GO:0098576
GeneOntologyCellularComponent	postsynaptic recycling endosome membrane	MYO5B ABHD17B	1.01e-03	6	174	2	GO:0098944
GeneOntologyCellularComponent	cell cortex	CNKSR1 MYO5B MYO10 SPTAN1 SPTB NUMA1 BFSP2 NOS2 EXOC4 NLRP5	1.13e-03	371	174	10	GO:0005938
GeneOntologyCellularComponent	vacuolar membrane	ANKFY1 HLA-A HLA-B HLA-C HLA-G SPG11 NCSTN SLC39A8 CSF3R C3AR1 GNB1 GNB2	1.14e-03	507	174	12	GO:0005774
GeneOntologyCellularComponent	lysosome	ANKFY1 PRSS57 HLA-A HLA-B HLA-C HLA-G SPG11 NCSTN SLC39A8 KLHL22 SIAE CSF3R C3AR1 ACP4 GNB1 GNB2	1.25e-03	811	174	16	GO:0005764
GeneOntologyCellularComponent	lytic vacuole	ANKFY1 PRSS57 HLA-A HLA-B HLA-C HLA-G SPG11 NCSTN SLC39A8 KLHL22 SIAE CSF3R C3AR1 ACP4 GNB1 GNB2	1.25e-03	811	174	16	GO:0000323
GeneOntologyCellularComponent	myosin complex	MYO5B MYO9A MYO10 MYO1B	1.48e-03	59	174	4	GO:0016459
GeneOntologyCellularComponent	vacuole	ANKFY1 PRSS57 HLA-A HLA-B HLA-C HLA-G SPG11 NCSTN CIT SLC39A8 KLHL22 SIAE CSF3R C3AR1 ACP4 GNB1 GNB2	1.65e-03	913	174	17	GO:0005773
GeneOntologyCellularComponent	ER to Golgi transport vesicle membrane	HLA-A HLA-B HLA-C HLA-G	2.00e-03	64	174	4	GO:0012507
GeneOntologyCellularComponent	actin-based cell projection	MYO10 ESPNL HLA-G MYO1B ADGRA2 UNC5C LHFPL5 EXOC4	2.35e-03	278	174	8	GO:0098858
GeneOntologyCellularComponent	RNA N6-methyladenosine methyltransferase complex	METTL4 VIRMA	2.39e-03	9	174	2	GO:0036396
GeneOntologyCellularComponent	spectrin	SPTAN1 SPTB	2.39e-03	9	174	2	GO:0008091
GeneOntologyCellularComponent	recycling endosome membrane	HLA-A HLA-B HLA-C HLA-G ABHD17B	2.47e-03	112	174	5	GO:0055038
GeneOntologyCellularComponent	tertiary granule	CAMP SPTAN1 CR1 PTPRB PTX3 NBEAL2	2.55e-03	164	174	6	GO:0070820
GeneOntologyCellularComponent	apical cortex	MYO5B NLRP5	2.97e-03	10	174	2	GO:0045179
GeneOntologyCellularComponent	Golgi stack	HLA-A HLA-B HLA-C HLA-G CIT MGAT2	3.13e-03	171	174	6	GO:0005795
GeneOntologyCellularComponent	Flemming body	BIRC6 KIF14 EXOC4	3.31e-03	36	174	3	GO:0090543
MousePheno	spinal cord inflammation	HLA-A HLA-B HLA-C HLA-G	5.01e-07	8	131	4	MP:0030987
MousePheno	demyelination	SH3TC2 HLA-A HLA-B HLA-C ATP8A2 HLA-G KIF14 C3AR1	1.26e-06	85	131	8	MP:0000921
MousePheno	abnormal motor coordination/balance	CACNA1A ANKFY1 MYO9A STXBP5L ATP8A2 SYNE1 LRRC4B SPG11 GPR88 CIT IFIT2 CREBBP MMAA MGAT2 STARD9 UNC5C KNDC1 LHFPL5 KIF14 HERC2 GNB1 ATP2A2	1.90e-05	873	131	22	MP:0001516
MousePheno	decreased susceptibility to autoimmune diabetes	HLA-A HLA-B HLA-C HLA-G MERTK	6.06e-05	45	131	5	MP:0004804
MousePheno	abnormal vertical activity	CACNA1A STXBP5L LRRC4B B3GNT7 GPR88 CREBBP MMAA PXDN TECPR2 PLXNC1 MEPCE SERAC1 GNB1 GNB2	6.33e-05	439	131	14	MP:0020167
MousePheno	increased vertical activity	STXBP5L LRRC4B B3GNT7 CREBBP PXDN TECPR2 PLXNC1 MEPCE GNB1 GNB2	1.21e-04	250	131	10	MP:0002574
MousePheno	CNS inflammation	HLA-A HLA-B HLA-C HLA-G NLRP1	1.47e-04	54	131	5	MP:0006082
MousePheno	abnormal myelination	SH3TC2 HLA-A HLA-B HLA-C ATP8A2 HLA-G KIF14 C3AR1	1.68e-04	166	131	8	MP:0000920
MousePheno	urolithiasis	HLA-B HLA-C SPTB HLA-G	1.90e-04	31	131	4	MP:0005360
MousePheno	ataxia	CACNA1A ANKFY1 MYO9A ATP8A2 SPG11 CIT IFIT2 STARD9 UNC5C KIF14	2.01e-04	266	131	10	MP:0001393
Domain	WD40_repeat	WDR31 STXBP5L HIRA STRN TULP4 TECPR2 NBEAL2 PWP2 WRAP73 HERC2 GNB1 GNB2	6.73e-06	272	168	12	IPR001680
Domain	WD_REPEATS_1	WDR31 STXBP5L HIRA STRN TULP4 TECPR2 NBEAL2 PWP2 WRAP73 HERC2 GNB1 GNB2	8.40e-06	278	168	12	PS00678
Domain	WD_REPEATS_2	WDR31 STXBP5L HIRA STRN TULP4 TECPR2 NBEAL2 PWP2 WRAP73 HERC2 GNB1 GNB2	8.71e-06	279	168	12	PS50082
Domain	WD_REPEATS_REGION	WDR31 STXBP5L HIRA STRN TULP4 TECPR2 NBEAL2 PWP2 WRAP73 HERC2 GNB1 GNB2	8.71e-06	279	168	12	PS50294
Domain	WD40/YVTN_repeat-like_dom	WDR31 STXBP5L BIRC6 HIRA STRN TULP4 TECPR2 PLXNC1 NBEAL2 PWP2 WRAP73 GNB1 GNB2	1.10e-05	335	168	13	IPR015943
Domain	MHC_I_a_C	HLA-A HLA-B HLA-C	1.40e-05	6	168	3	IPR010579
Domain	MHC_I_C	HLA-A HLA-B HLA-C	1.40e-05	6	168	3	PF06623
Domain	WD40	WDR31 STXBP5L HIRA STRN TULP4 TECPR2 NBEAL2 PWP2 WRAP73 GNB1 GNB2	3.20e-05	268	168	11	SM00320
Domain	MHC_I	HLA-A HLA-B HLA-C HLA-G	3.35e-05	21	168	4	PF00129
Domain	MHC_I_a_a1/a2	HLA-A HLA-B HLA-C HLA-G	3.35e-05	21	168	4	IPR001039
Domain	-	WDR31 STXBP5L BIRC6 HIRA STRN TULP4 TECPR2 PLXNC1 NBEAL2 WRAP73 GNB1 GNB2	4.98e-05	333	168	12	2.130.10.10
Domain	Ig-like_dom	HLA-A HLA-B HLA-C MMP23B HLA-G LRRC4B ADGRA2 CD3E PXDN CSF3R UNC5C SIGLEC1 MERTK CD96 ADGRA3	5.10e-05	503	168	15	IPR007110
Domain	-	HLA-A HLA-B HLA-C HLA-G	5.83e-05	24	168	4	3.30.500.10
Domain	MHC_I-like_Ag-recog	HLA-A HLA-B HLA-C HLA-G	5.83e-05	24	168	4	IPR011161
Domain	-	HLA-A HLA-B HLA-C MMP23B HLA-G LRRC4B ADGRA2 CD3E PTPRB PXDN CSF3R PLXNC1 UNC5C SIGLEC1 MERTK CD96 ADGRA3	1.03e-04	663	168	17	2.60.40.10
Domain	WD40	WDR31 STXBP5L HIRA STRN TULP4 NBEAL2 PWP2 WRAP73 GNB1 GNB2	1.22e-04	259	168	10	PF00400
Domain	IG_LIKE	HLA-A HLA-B HLA-C MMP23B HLA-G LRRC4B ADGRA2 CD3E PXDN UNC5C SIGLEC1 MERTK CD96 ADGRA3	1.46e-04	491	168	14	PS50835
Domain	Ig-like_fold	HLA-A HLA-B HLA-C MMP23B HLA-G LRRC4B ADGRA2 CD3E PTPRB PXDN CSF3R PLXNC1 UNC5C SIGLEC1 MERTK CD96 ADGRA3	2.18e-04	706	168	17	IPR013783
Domain	TECPR	TECPR2 HERC2	2.40e-04	3	168	2	SM00706
Domain	Beta-propeller_rpt_TECPR	TECPR2 HERC2	2.40e-04	3	168	2	IPR006624
Domain	WD40_repeat_dom	WDR31 STXBP5L HIRA STRN TULP4 TECPR2 NBEAL2 PWP2 GNB1 GNB2	3.67e-04	297	168	10	IPR017986
Domain	Myosin_head_motor_dom	MYO5B MYO9A MYO10 MYO1B	3.67e-04	38	168	4	IPR001609
Domain	MYOSIN_MOTOR	MYO5B MYO9A MYO10 MYO1B	3.67e-04	38	168	4	PS51456
Domain	Myosin_head	MYO5B MYO9A MYO10 MYO1B	3.67e-04	38	168	4	PF00063
Domain	MYSc	MYO5B MYO9A MYO10 MYO1B	3.67e-04	38	168	4	SM00242
Domain	MHC_I/II-like_Ag-recog	HLA-A HLA-B HLA-C HLA-G	3.67e-04	38	168	4	IPR011162
Domain	WD40_repeat_CS	WDR31 STXBP5L HIRA STRN PWP2 GNB1 GNB2	7.17e-04	164	168	7	IPR019775
Domain	Guanine_nucleotide-bd_bsu	GNB1 GNB2	7.90e-04	5	168	2	IPR016346
Domain	G-protein_beta_WD-40_rep	WDR31 STRN PWP2 GNB1 GNB2	1.02e-03	85	168	5	IPR020472
Domain	NACHT	NLRP1 NLRC3 NLRP5	1.11e-03	23	168	3	PS50837
Domain	NACHT_NTPase	NLRP1 NLRC3 NLRP5	1.11e-03	23	168	3	IPR007111
Domain	Spectrin	SYNE1 SPTAN1 SPTB	1.11e-03	23	168	3	PF00435
Domain	Val/Leu/Ile-tRNA-synth_edit	VARS2 LARS2	1.18e-03	6	168	2	IPR009008
Domain	Anticodon_1	VARS2 LARS2	1.18e-03	6	168	2	PF08264
Domain	M/V/L/I-tRNA-synth_anticd-bd	VARS2 LARS2	1.18e-03	6	168	2	IPR013155
Domain	-	VARS2 LARS2	1.18e-03	6	168	2	3.90.740.10
Domain	C1-set	HLA-A HLA-B HLA-C HLA-G	1.41e-03	54	168	4	PF07654
Domain	IGc1	HLA-A HLA-B HLA-C HLA-G	1.61e-03	56	168	4	SM00407
Domain	aa-tRNA-synth_Ia	VARS2 LARS2	1.64e-03	7	168	2	IPR002300
Domain	tRNA-synt_1	VARS2 LARS2	1.64e-03	7	168	2	PF00133
Domain	Ig/MHC_CS	HLA-A HLA-B HLA-C HLA-G	1.84e-03	58	168	4	IPR003006
Domain	Ig_C1-set	HLA-A HLA-B HLA-C HLA-G	1.84e-03	58	168	4	IPR003597
Pathway	KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B HLA-C HLA-G	9.59e-08	6	128	4	M47468
Pathway	KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B HLA-C HLA-G	2.22e-07	7	128	4	M47582
Pathway	KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B HLA-C HLA-G	2.22e-07	7	128	4	M47530
Pathway	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY	HLA-A HLA-B HLA-C HLA-G	7.89e-07	9	128	4	MM14527
Pathway	BIOCARTA_CTL_PATHWAY	HLA-A HLA-B HLA-C HLA-G CD3E	7.93e-07	20	128	5	MM1374
Pathway	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY	HLA-A HLA-B HLA-C HLA-G	2.04e-06	11	128	4	M525
Pathway	KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B HLA-C HLA-G	3.03e-06	12	128	4	M47529
Pathway	REACTOME_ER_PHAGOSOME_PATHWAY	HLA-A HLA-B HLA-C HLA-G	1.80e-05	18	128	4	MM14525
Pathway	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	HLA-A HLA-B HLA-C HLA-G	7.08e-05	25	128	4	MM15713
Pathway	BIOCARTA_NKCELLS_PATHWAY	HLA-A HLA-B HLA-C HLA-G	7.08e-05	25	128	4	MM1465
Pathway	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	HLA-A HLA-B HLA-C HLA-G	1.29e-04	29	128	4	M1062
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	HLA-A HLA-B HLA-C HLA-G CD3E SIGLEC1 CD96	2.28e-04	135	128	7	MM14781
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	HLA-A HLA-B HLA-C HLA-G IGLV3-21 CD3E SIGLEC1 CD96	3.39e-04	190	128	8	M8240
Pathway	KEGG_ALLOGRAFT_REJECTION	HLA-A HLA-B HLA-C HLA-G	3.40e-04	37	128	4	M18615
Pathway	KEGG_GRAFT_VERSUS_HOST_DISEASE	HLA-A HLA-B HLA-C HLA-G	5.06e-04	41	128	4	M13519
Pathway	KEGG_TYPE_I_DIABETES_MELLITUS	HLA-A HLA-B HLA-C HLA-G	6.08e-04	43	128	4	M12617
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_CIT	PPP1R12B CIT KIF14	6.37e-04	19	128	3	M27489
Pubmed	gp 120s derived from four syncytium-inducing HIV-1 strains induce different patterns of CD4 association with lymphocyte surface molecules.	HLA-A HLA-B HLA-C HLA-G CD3E PTPRB	5.83e-10	20	177	6	9263011
Pubmed	Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily.	HLA-A HLA-B HLA-C HLA-G	6.48e-10	4	177	4	11861287
Pubmed	Soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.	HLA-A HLA-B HLA-C HLA-G	6.48e-10	4	177	4	18782112
Pubmed	Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution.	HLA-A HLA-B HLA-C HLA-G	6.48e-10	4	177	4	19762282
Pubmed	Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.	HLA-A HLA-B HLA-C HLA-G	6.48e-10	4	177	4	16459714
Pubmed	Interferon-γ-Driven iNOS: A Molecular Pathway to Terminal Shock in Arenavirus Hemorrhagic Fever.	HLA-A HLA-B HLA-C HLA-G NOS2	7.96e-10	10	177	5	28826838
Pubmed	A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory.	HLA-A HLA-B HLA-C HLA-G CD3E	7.96e-10	10	177	5	12242444
Pubmed	HIV-1 Nef: at the crossroads.	HLA-A HLA-B HLA-C HLA-G CD3E	1.45e-09	11	177	5	18808677
Pubmed	Chromosomal localization of genes encoding guanine nucleotide-binding protein subunits in mouse and human.	HLA-A HLA-B HLA-C HLA-G GNB1 GNB2	1.99e-09	24	177	6	2902634
Pubmed	The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer.	HLA-A HLA-B HLA-C HLA-G	3.23e-09	5	177	4	19728333
Pubmed	The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies.	HLA-A HLA-B HLA-C HLA-G	3.23e-09	5	177	4	27522114
Pubmed	Distinct trafficking pathways mediate Nef-induced and clathrin-dependent major histocompatibility complex class I down-regulation.	HLA-A HLA-B HLA-C HLA-G	9.65e-09	6	177	4	10982373
Pubmed	Effect of the V3 loop deletion of envelope glycoprotein on cellular responses and protection against challenge with recombinant vaccinia virus expressing gp160 of primary human immunodeficiency virus type 1 isolates.	HLA-A HLA-B HLA-C HLA-G	9.65e-09	6	177	4	11932387
Pubmed	Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes.	HLA-A HLA-B HLA-C HLA-G	9.65e-09	6	177	4	8671651
Pubmed	The dileucine-based sorting motif in HIV-1 Nef is not required for down-regulation of class I MHC.	HLA-A HLA-B HLA-C HLA-G	9.65e-09	6	177	4	10366557
Pubmed	The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes.	HLA-A HLA-B HLA-C HLA-G	9.65e-09	6	177	4	9582271
Pubmed	Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class I molecules.	HLA-A HLA-B HLA-C HLA-G	9.65e-09	6	177	4	10546855
Pubmed	Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.	HLA-A HLA-B HLA-C HLA-G	9.65e-09	6	177	4	10799863
Pubmed	The cationic region from HIV tat enhances the cell-surface expression of epitope/MHC class I complexes.	HLA-A HLA-B HLA-C HLA-G	9.65e-09	6	177	4	14595379
Pubmed	HIV immune evasion disruption of antigen presentation by the HIV Nef protein.	HLA-A HLA-B HLA-C HLA-G	9.65e-09	6	177	4	21762823
Pubmed	The immunosuppressive peptide of HIV-1 gp41 like human type I interferons up-regulates MHC class I expression on H9 and U937 cells.	HLA-A HLA-B HLA-C HLA-G	9.65e-09	6	177	4	9373217
Pubmed	Nef-mediated MHC class I down-regulation unmasks clonal differences in virus suppression by SIV-specific CD8(+) T cells independent of IFN-gamma and CD107a responses.	HLA-A HLA-B HLA-C HLA-G	9.65e-09	6	177	4	19555986
Pubmed	Degenerate MHC restriction reveals the contribution of class I MHC molecules in determining the fine specificity of CTL recognition of an immunodominant determinant of HIV-1 gp160 V3 loop.	HLA-A HLA-B HLA-C HLA-G	9.65e-09	6	177	4	9120272
Pubmed	On the role of the second coding exon of the HIV-1 Tat protein in virus replication and MHC class I downregulation.	HLA-A HLA-B HLA-C HLA-G	9.65e-09	6	177	4	9840288
Pubmed	A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160.	HLA-A HLA-B HLA-C HLA-G	9.65e-09	6	177	4	2789433
Pubmed	Spatial and functional relationship of GGAs and AP-1 in Drosophila and HeLa cells.	HLA-A HLA-B HLA-C HLA-G	9.65e-09	6	177	4	19847956
Pubmed	Repression of MHC class I gene promoter activity by two-exon Tat of HIV.	HLA-A HLA-B HLA-C HLA-G	9.65e-09	6	177	4	8493575
Pubmed	Minor contribution of HLA class I-associated selective pressure to the variability of HIV-1 accessory protein Vpu.	HLA-A HLA-B HLA-C HLA-G	9.65e-09	6	177	4	22503975
Pubmed	Three regions of HIV-1 gp160 contain clusters of immunodominant CTL epitopes.	HLA-A HLA-B HLA-C HLA-G	9.65e-09	6	177	4	8877415
Pubmed	Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein.	HLA-A HLA-B HLA-C HLA-G	9.65e-09	6	177	4	8612235
Pubmed	Generation of a functional cDNA encoding the LdH2 class-I molecule by using a single-LTR retroviral shuttle vector.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	1705528
Pubmed	Further studies on polymorphic expression of GM1 and GD1a in mouse liver. The presence of a third allele on the Ggm-1 locus.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	2808323
Pubmed	Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	9586638
Pubmed	CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	21088134
Pubmed	The Tla locus: a new allele and antigenic specificity.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	69663
Pubmed	Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	12459592
Pubmed	Multiple sequences related to classical histocompatibility antigens in the mouse genome.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	6264319
Pubmed	Sequence analysis of the C3H H-2K1k gene: relationship to the H-2 loci.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	2714856
Pubmed	Class I MHC molecules on hematopoietic cells can support intrathymic positive selection of T cell receptor transgenic T cells.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	10500200
Pubmed	Structural analysis of H-2Kf and H-2Kfm1 by using H-2K locus-specific sequences.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	2391419
Pubmed	Embryonic mouse STO cell-derived xenografts express hepatocytic functions in the livers of nonimmunosuppressed adult rats.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	15671142
Pubmed	GENETIC BASIS OF SUSCEPTIBILITY TO VIRAL LEUKAEMOGENESIS.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	14215561
Pubmed	A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	28234229
Pubmed	Interaction of H-2Db with mutant histocompatibility gene H (KH-11) in the mouse.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	6242891
Pubmed	Characterization of a severe parenchymal phenotype of experimental autoimmune encephalomyelitis in (C57BL6xB10.PL)F1 mice.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	17512611
Pubmed	Amino acid sequence of residues 1-98 of the K-2Kb murine major histocompatibility alloantigen: comparison with H-2Kb and H-2db reveals extensive localized differences.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	7018573
Pubmed	Induction of the H-2 D antigen during B cell activation.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	2642506
Pubmed	A complex major histocompatibility complex D locus variant generated by an unusual recombination mechanism in mice.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	9037062
Pubmed	Simultaneous assessment of CD4 and MHC-I downregulation by Nef primary isolates in the context of infection.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	19643141
Pubmed	Nucleic acid sequences of the H-2Ks and H-2Ksm1 genes.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	1840571
Pubmed	Natural killer cell tolerance persists despite significant reduction of self MHC class I on normal target cells in mice.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	20957233
Pubmed	Zooming in on the hydrophobic ridge of H-2D(b): implications for the conformational variability of bound peptides.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	11580250
Pubmed	V beta T cell repertoire of CD8+ splenocytes selected on nonpolymorphic MHC class I molecules.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	11086076
Pubmed	HLA-B*0702 transgenic, H-2KbDb double-knockout mice: phenotypical and functional characterization in response to influenza virus.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	12750360
Pubmed	Major histocompatibility complex (Mhc) class Ib gene duplications, organization and expression patterns in mouse strain C57BL/6.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	18416856
Pubmed	Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	20974936
Pubmed	The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	10704462
Pubmed	West Nile virus T-cell ligand sequences shared with other flaviviruses: a multitude of variant sequences as potential altered peptide ligands.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	22573867
Pubmed	A novel H-2K splice form: predictions for other alternative H-2 splicing events.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	2908875
Pubmed	Comparison of exon 5 sequences from 35 class I genes of the BALB/c mouse.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	2584927
Pubmed	Transcripts of Tla genes.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	3496275
Pubmed	Comparative analysis of the CD8(+) T cell repertoires of H-2 class I wild-type/HLA-A2.1 and H-2 class I knockout/HLA-A2.1 transgenic mice.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	12147629
Pubmed	Mitotic recombination in germ cells generated two major histocompatibility complex mutant genes shown to be identical by RNA sequence analysis: Kbm9 and Kbm6.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	3458188
Pubmed	Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	12414957
Pubmed	Antigens expressed by myelinating glia cells induce peripheral cross-tolerance of endogenous CD8+ T cells.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	19462379
Pubmed	Structural diversity of the classical H-2 genes: K, D, and L.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	1730883
Pubmed	DNA sequence analysis of the C3H H-2Kk and H-2Dk loci. Evolutionary relationships to H-2 genes from four other mouse strains.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	3680952
Pubmed	Thymus leukemia antigen controls intraepithelial lymphocyte function and inflammatory bowel disease.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	19004778
Pubmed	Comparison of the cloned H-2Kbm1 variant gene with the H-2Kb gene shows a cluster of seven nucleotide differences.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	6300887
Pubmed	H-2-linked regulation of xenotropic murine leukemia virus expression.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	6300850
Pubmed	The assembly of H2-Kb class I molecules translated in vitro requires oxidized glutathione and peptide.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	8500526
Pubmed	cDNA clone coding for part of a mouse H-2d major histocompatibility antigen.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	6265910
Pubmed	Cutting edge: MHC class I-Ly49 interaction regulates neuronal function.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	18453559
Pubmed	DNA polymorphisms defined by the Tu108 probe map to the Tla region of mouse chromosome 17.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	2906539
Pubmed	A single nucleotide difference at the 3' end of an intron causes differential splicing of two histocompatibility genes.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	3013627
Pubmed	CD4 and MHC class 1 down-modulation activities of nef alleles from brain- and lymphoid tissue-derived primary HIV-1 isolates.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	21165790
Pubmed	DNA sequence of the mouse H-2Dd transplantation antigen gene.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	3856254
Pubmed	Structure of a gene encoding a murine thymus leukemia antigen, and organization of Tla genes in the BALB/c mouse.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	3894562
Pubmed	Recognition of the Major Histocompatibility Complex (MHC) Class Ib Molecule H2-Q10 by the Natural Killer Cell Receptor Ly49C.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	27385590
Pubmed	Evolution of the mouse H-2K region: a hot spot of mutation associated with genes transcribed in embryos and/or germ cells.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	1348042
Pubmed	H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	19346486
Pubmed	Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	18383043
Pubmed	Thymus-dependent memory phenotype CD8 T cells in naive B6.H-2Kb-/-Db-/- animals mediate an antigen-specific response against Listeria monocytogenes.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	16272298
Pubmed	Tissue-specific expression of an unusual H-2 (class I)-related gene.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	6956903
Pubmed	A physical map of the Q region of B1O.P.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	8833240
Pubmed	Transplantation tolerance to a single noninherited MHC class I maternal alloantigen studied in a TCR-transgenic mouse model.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	21178009
Pubmed	Expression and function of transplantation antigens with altered or deleted cytoplasmic domains.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	6604582
Pubmed	Isolation of a cDNA clone for the murine transplantation antigen H-2Kb.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	6954478
Pubmed	CD4 T cell help prevents CD8 T cell exhaustion and promotes control of Mycobacterium tuberculosis infection.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	34525366
Pubmed	The H-2Kkml mutation: a single nucleotide substitution is responsible for multiple functional differences in a class I MHC molecule.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	3374494
Pubmed	Extensive deletions in the Q region of the mouse major histocompatibility complex.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	3025084
Pubmed	DNA sequence of a class I pseudogene from the Tla region of the murine MHC: recombination at a B2 alu repetitive sequence.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	2543831
Pubmed	The class I major histocompatibility antigen gene activated in a line of SV40-transformed mouse cells is H-2Dd, not Qa/Tla.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	2989712
Pubmed	Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	1280760
Pubmed	Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	6786753
Pubmed	Detection of a secreted form of the murine H-2 class I antigen with an antibody against its predicted carboxyl terminus.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	6583704
Pubmed	Expression of H-2Dd and H-2Ld mouse major histocompatibility antigen genes in L cells after DNA-mediated gene transfer.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	6571712
Pubmed	Mutation of a major histocompatibility class I locus, H-2D, leads to an increased virus burden and disease susceptibility in Theiler's virus-induced demyelinating disease.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	9222352
Pubmed	Probing for membrane domains in the endoplasmic reticulum: retention and degradation of unassembled MHC class I molecules.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	12006653
Pubmed	Changes in the coding sequence of the H-2Dk gene of metastatic cells that might account for immunogenic abnormality of its encoded antigen.	HLA-A HLA-B HLA-C HLA-G	2.24e-08	7	177	4	1699529
Interaction	LILRB1 interactions	HLA-A HLA-B HLA-C HLA-G	9.19e-07	10	167	4	int:LILRB1
Interaction	LILRB2 interactions	HLA-A HLA-B HLA-C HLA-G	9.19e-07	10	167	4	int:LILRB2
Interaction	NPTN interactions	ARFGEF1 SPG11 LARS2 FOCAD ANKRD44 MDN1 NBEAL2 ANAPC2 KIF14 HEATR5B ATP2A2 SEC14L1	3.68e-06	278	167	12	int:NPTN
Interaction	TMOD1 interactions	MYO5B SPTAN1 MYO1B TRRAP CLEC4E ARFGAP2 STRN CCDC138 KIF14	8.08e-06	161	167	9	int:TMOD1
Interaction	CLEC4E interactions	TOR1AIP2 HLA-A HLA-B HLA-C SPTAN1 SPTB MYO1B TMEM214 CLEC4E ARFGAP2 GNB1 GNB2 ATP2A2	8.11e-06	353	167	13	int:CLEC4E
Interaction	ARHGAP30 interactions	ARHGEF28 ARHGEF18 VIRMA DOCK7	1.60e-05	19	167	4	int:ARHGAP30
Interaction	GPR182 interactions	HLA-C ARFGEF1 COX15 SPG11 VARS2 LARS2 FOCAD MDN1 ABHD17B NBEAL2 CCDC138 PAQR3 EXOC4 SEC14L1	2.72e-05	455	167	14	int:GPR182
Interaction	SYNPO interactions	MYO5B PPP1R12B SPTAN1 MYO1B CIT VIRMA KIF14 GNB1 GNB2	3.29e-05	192	167	9	int:SYNPO
Interaction	CNTRL interactions	ARHGEF18 TRRAP VIRMA CREBBP CCDC138 PWP2 WRAP73 KIF14 EXOC4	3.42e-05	193	167	9	int:CNTRL
Interaction	STAG3 interactions	TRRAP CIT ANAPC2 KIF14	3.56e-05	23	167	4	int:STAG3
Interaction	HSP90B2P interactions	CIT VIRMA KIF14 HERC2	5.02e-05	25	167	4	int:HSP90B2P
Interaction	CD8A interactions	HLA-A HLA-B HLA-C HLA-G	5.90e-05	26	167	4	int:CD8A
Interaction	ANAPC7 interactions	NUMA1 SMARCAD1 USP37 TRRAP CIT VIRMA CREBBP ANAPC2	6.29e-05	162	167	8	int:ANAPC7
Interaction	DDX4 interactions	TOR1AIP2 CIT MEPCE KIF14	6.88e-05	27	167	4	int:DDX4
Interaction	TTC3 interactions	SPTAN1 CIT VIRMA ANAPC2 HERC2 ATP2A2 EXOC4	7.90e-05	124	167	7	int:TTC3
Interaction	SPTB interactions	SPTAN1 SPTB CIT VIRMA CLEC4E KIF14	8.58e-05	87	167	6	int:SPTB
Interaction	PLA2G1B interactions	KLHL22 CSF3R UBR3	8.78e-05	11	167	3	int:PLA2G1B
Interaction	ANK1 interactions	PPP1R12B SPTAN1 SPTB SLC30A8 VIRMA	9.99e-05	56	167	5	int:ANK1
GeneFamily	WD repeat domain containing	WDR31 STXBP5L HIRA STRN TULP4 NBEAL2 PWP2 WRAP73 GNB1 GNB2	2.77e-05	262	135	10	362
GeneFamily	Immunoglobulin like domain containing\|Adhesion G protein-coupled receptors, subfamily A	ADGRA2 ADGRA3	1.65e-04	3	135	2	911
GeneFamily	C1-set domain containing	HLA-A HLA-B HLA-C HLA-G	2.67e-04	42	135	4	591
GeneFamily	Histocompatibility complex\|C1-set domain containing	HLA-A HLA-B HLA-C HLA-G	3.20e-04	44	135	4	588
GeneFamily	NLR family	NLRP1 NLRC3 NLRP5	8.30e-04	25	135	3	666
GeneFamily	EF-hand domain containing\|Spectrins	SPTAN1 SPTB	1.13e-03	7	135	2	1113
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	LRRC4B PXDN UNC5C SIGLEC1 MERTK ADGRA3	1.33e-03	161	135	6	593
GeneFamily	Complement system\|Sushi domain containing	CR1 CFB C3AR1	2.43e-03	36	135	3	492
GeneFamily	Maestro heat like repeat containing	MROH5 MROH2B	2.91e-03	11	135	2	636
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	ANKFY1 BTBD17 KLHL22 ZBTB39 KLHL4	3.33e-03	134	135	5	861
Coexpression	GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN	ANKFY1 HLA-A HLA-B HLA-C HLA-G LARS2 IFIT2 CFB CD3E CD96	8.75e-07	200	172	10	M9570
Coexpression	CASTELLANO_NRAS_TARGETS_UP	HLA-A HLA-B HLA-C HLA-G TULP4 PTX3 EXOC4	1.88e-06	88	172	7	MM1087
Coexpression	TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING	HLA-A HLA-B HLA-C HLA-G	3.06e-06	16	172	4	MM3766
Coexpression	PAL_PRMT5_TARGETS_DN	HLA-A HLA-B HLA-C HLA-G SERPINE1	3.18e-06	35	172	5	MM674
Coexpression	TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING	HLA-A HLA-B HLA-C SYNE1 HLA-G	5.52e-06	39	172	5	MM3725
Coexpression	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN	HLA-A HLA-B HLA-C HLA-G	6.43e-06	19	172	4	MM797
Coexpression	MIKKELSEN_NPC_ICP_WITH_H3K27ME3	HLA-A HLA-B HLA-C HLA-G	6.43e-06	19	172	4	MM862
Coexpression	GSE7460_TREG_VS_TCONV_ACT_DN	MYO10 BCORL1 POLRMT CCDC175 VARS2 FOCAD CLEC4E NME6 MERTK	6.52e-06	197	172	9	M5691
Coexpression	TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING	HLA-A HLA-B HLA-C HLA-G	7.99e-06	20	172	4	MM3682
Coexpression	RUAN_RESPONSE_TO_TNF_UP	HLA-A HLA-B HLA-C HLA-G	9.82e-06	21	172	4	MM651
Coexpression	ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE	HLA-A HLA-B HLA-C MYO9A HLA-G BIRC6 KLHL22 STARD9 NLRC3	1.13e-05	211	172	9	MM17081
Coexpression	TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING	HLA-A HLA-B HLA-C HLA-G	1.72e-05	24	172	4	MM3773
Coexpression	BAUS_TFF2_TARGETS_UP	HLA-A HLA-B HLA-C HLA-G GNB1	1.73e-05	49	172	5	MM1287
Coexpression	TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING	CACNA1A CYB5D2 NR2C1 HLA-A HLA-B HLA-C HLA-G LRRC4B TRRAP ADGRA2 MTMR10 AARSD1 FOCAD DOCK7 LHFPL5 GNB2 HEATR5B PRRC1 SEC14L1	1.76e-05	954	172	19	MM3689
Coexpression	TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING	HLA-A HLA-B HLA-C CAMP HLA-G	1.92e-05	50	172	5	MM3805
Coexpression	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP	HLA-A HLA-B HLA-C HLA-G	2.03e-05	25	172	4	MM672
Coexpression	TABULA_MURIS_SENIS_MARROW_NAIVE_T_CELL_AGEING	HLA-A HLA-B HLA-C CAMP HLA-G	2.32e-05	52	172	5	MM3808
Coexpression	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP	HLA-A HLA-B HLA-C HLA-G CIT SERPINE1	2.38e-05	87	172	6	MM652
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	MYO10 PPP1R12B USP37 BIRC6 CREBBP TULP4 KIF14 ATP2A2	2.62e-05	180	172	8	M8239
Coexpression	SERVITJA_ISLET_HNF1A_TARGETS_UP	HLA-A HLA-B HLA-C STXBP5L PARP3 HLA-G IFIT2 CACNG5	3.18e-05	185	172	8	MM1072
Coexpression	TABULA_MURIS_SENIS_HEART_ENDOCARDIAL_CELL_AGEING	HLA-A HLA-B HLA-C HLA-G GNB1	4.31e-05	59	172	5	MM3704
Coexpression	TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING	HLA-A HLA-B HLA-C HLA-G	4.91e-05	31	172	4	MM3729
Coexpression	GSE22886_CTRL_VS_LPS_24H_DC_DN	HLA-A HLA-B HLA-G SPG11 IFIT2 CFB TMEM39A PAQR3	5.53e-05	200	172	8	M4520
Coexpression	GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_UP	NCSTN AGBL5 KLHL22 MMAA SIAE MEPCE UBR3 EXOC4	5.53e-05	200	172	8	M7742
Coexpression	GSE40273_GATA1_KO_VS_WT_TREG_DN	NR2C1 ANKFY1 SYNE1 SPTAN1 PARP3 ARHGEF18 PLXNC1 ERMARD	5.53e-05	200	172	8	M9133
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN	HLA-A HLA-B HLA-C HLA-G COLEC10 HIRA	6.18e-05	103	172	6	MM476
Coexpression	ZENG_GU_POST_ICB_METAGENE_31	HLA-B HLA-C HLA-G CFB CD3E NBEAL2 ERMARD FERMT3	7.53e-05	209	172	8	MM17088
Coexpression	TABULA_MURIS_SENIS_MARROW_HEMATOPOIETIC_PRECURSOR_CELL_AGEING	HLA-A HLA-B HLA-C CAMP HLA-G CD3E	1.09e-04	114	172	6	MM3799
Coexpression	GAURNIER_PSMD4_TARGETS	HLA-A HLA-B HLA-C HLA-G C3AR1	1.20e-04	73	172	5	M11428
Coexpression	TABULA_MURIS_SENIS_LUNG_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING	HLA-A HLA-B HLA-C HLA-G	1.23e-04	39	172	4	MM3758
Coexpression	TABULA_MURIS_SENIS_MARROW_GRANULOCYTE_AGEING	HLA-A HLA-B HLA-C CAMP HLA-G	1.28e-04	74	172	5	MM3796
Coexpression	BROWNE_HCMV_INFECTION_14HR_DN	MYO10 SYNE1 SPTB NUMA1 NLRP1 MYO1B CIT SERPINE1 ATP2A2	1.34e-04	290	172	9	M13251
Coexpression	TABULA_MURIS_SENIS_KIDNEY_BRUSH_CELL_AGEING	HLA-A HLA-B HLA-C HLA-G CFB	1.37e-04	75	172	5	MM3718
Coexpression	HOWLIN_CITED1_TARGETS_1_UP	HLA-A HLA-B HLA-C HLA-G	1.50e-04	41	172	4	MM710
Coexpression	TRAVAGLINI_LUNG_NEUTROPHIL_CELL	HLA-B SPTAN1 CR1 ANKRD44 CLEC4E CSF3R PLXNC1 NBEAL2 GNB2 SEC14L1	1.61e-04	366	172	10	M41688
Coexpression	HU_GENOTOXIC_DAMAGE_4HR	HLA-A HLA-B HLA-C HLA-G	1.81e-04	43	172	4	MM1204
Coexpression	TABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING	HLA-A HLA-B HLA-C HLA-G	1.98e-04	44	172	4	MM3775
Coexpression	TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_B_CELL_AGEING	HLA-A HLA-B HLA-C HLA-G GNB1	2.08e-04	82	172	5	MM3777
Coexpression	TABULA_MURIS_SENIS_TRACHEA_MACROPHAGE_AGEING	HLA-A HLA-B HLA-C HLA-G GNB1	2.08e-04	82	172	5	MM3858
Coexpression	TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOCARDIAL_CELL_AGEING	HLA-A HLA-B HLA-C HLA-G	2.36e-04	46	172	4	MM3712
Coexpression	FAN_EMBRYONIC_CTX_BRAIN_EFFECTOR_T_CELL	HLA-A HLA-B HLA-C SYNE1 CD3E CD96	2.42e-04	132	172	6	M39046
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	MYO10 ARFGEF1 MYO1B LARS2 TRRAP CREBBP HIRA MDN1 SERPINE1 KIF14 SEC14L1	2.71e-04	466	172	11	M13522
Coexpression	TABULA_MURIS_SENIS_LUNG_B_CELL_AGEING	HLA-A HLA-B HLA-C HLA-G ANKRD44	3.22e-04	90	172	5	MM3756
Coexpression	COATES_MACROPHAGE_M1_VS_M2_DN	HLA-A HLA-B HLA-C HLA-G TULP4	3.22e-04	90	172	5	MM750
Coexpression	TABULA_MURIS_SENIS_KIDNEY_FENESTRATED_CELL_AGEING	HLA-A HLA-B HLA-C HLA-G CFB	3.39e-04	91	172	5	MM3720
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	MYO5B SYNE1 PPP1R12B PARP3 BTBD17 PRAG1 MTMR10 HIRA FOCAD ANKRD44 STRN PXDN TULP4 PLXNC1 DOCK7 BFSP2 CABIN1 ERMARD	3.53e-04	1102	172	18	M2369
Coexpression	GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN	HLA-A HLA-C PARP3 HLA-G LARS2 IFIT2 CFB	3.56e-04	199	172	7	M9595
Coexpression	GSE360_L_MAJOR_VS_T_GONDII_MAC_DN	NR2C1 PARP3 COLEC10 TRRAP ARFGAP2 MDN1 TECPR2	3.56e-04	199	172	7	M5246
Coexpression	TABULA_MURIS_SENIS_LIMB_MUSCLE_SMOOTH_MUSCLE_CELL_AGEING	HLA-A HLA-B HLA-C HLA-G MYO1B	3.56e-04	92	172	5	MM3748
Coexpression	GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP	STXBP5L BCORL1 USP37 VIRMA KLHL22 ANKRD44 STRN	3.67e-04	200	172	7	M9317
Coexpression	GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN	HLA-A HLA-B HLA-C PARP3 HLA-G IFIT2 CFB	3.67e-04	200	172	7	M9586
Coexpression	GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_DN	APTX MMP23B HLA-G LARS2 LETM1 KLHL22 PXDN	3.67e-04	200	172	7	M7347
Coexpression	GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_DN	HLA-C MTMR10 MGAT2 PWP2 MEPCE UBR3 EXOC4	3.67e-04	200	172	7	M4044
Coexpression	HALLMARK_KRAS_SIGNALING_UP	TOR1AIP2 ADGRA2 MTMR10 CFB STRN C3AR1 NR1H4	3.67e-04	200	172	7	M5953
Coexpression	MARKEY_RB1_ACUTE_LOF_DN	TOR1AIP2 HLA-A HLA-B HLA-C HLA-G IFIT2 C3AR1 FERMT3	4.00e-04	267	172	8	MM1091
ToppCell	COVID-19-kidney-Myeloid\|kidney / Disease (COVID-19 only), tissue and cell type	HLA-A HLA-B HLA-C CR1 ANKRD44 CLEC4E CSF3R PLXNC1 C3AR1	7.64e-08	192	176	9	441cd1ec171f643b28e1f6f9c04def629cc7391b
ToppCell	(6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)\|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	HLA-A HLA-B HLA-C SYNE1 COLEC10 CLEC4E SERPINE1 NOS2	2.17e-07	157	176	8	84f629b7f589ca8a1abc220fa740c4a6fdc1b579
ToppCell	3'_v3-blood-Lymphocytic_T_CD8\|blood / Manually curated celltypes from each tissue	HLA-A HLA-C SYNE1 ANKRD44 DIP2A CD3E NLRC3 CD96	9.26e-07	190	176	8	5dca8654964c41580fa3b094579fe7cb296d406f
ToppCell	normal_Pleural_Fluid-T/NK_cells-NK\|normal_Pleural_Fluid / Location, Cell class and cell subclass	HLA-A HLA-B HLA-C SYNE1 MMP23B B3GNT7 STARD9 CD96	1.00e-06	192	176	8	59dd4f5ae9f1cca78adf60b71661092ef09e6641
ToppCell	RA-09._Endothelium_I\|RA / Chamber and Cluster_Paper	CPAMD8 HLA-B HLA-C MYO10 SYNE1 PRAG1 PTPRB SEC14L1	1.00e-06	192	176	8	8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc
ToppCell	Int-URO-Lymphocyte-T_NK-NK\|Int-URO / Disease, Lineage and Cell Type	PRSS57 HLA-A HLA-B HLA-C SYNE1 MMP23B NLRC3 CD96	1.04e-06	193	176	8	5c7942f630fc69374df34ee3602ad973b6ced17a
ToppCell	IPF-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	HLA-A HLA-B HLA-C SYNE1 COLEC10 CLEC4E SERPINE1 NOS2	1.08e-06	194	176	8	777ce41c3f22c591e2d81120f189b834e53ffb4b
ToppCell	severe_COVID-19-CD4+_CTL\|World / disease group, cell group and cell class (v2)	HLA-A HLA-B HLA-C SYNE1 IFIT2 DIP2A CD3E CD96	1.08e-06	194	176	8	bdafc1173b7b8cde8714573fbeee5394a2484a5f
ToppCell	LA-09._Endothelium_I\|World / Chamber and Cluster_Paper	CPAMD8 HLA-A HLA-B HLA-C SYNE1 PRAG1 PTPRB SEC14L1	1.13e-06	195	176	8	fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_NK\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PRSS57 HLA-A HLA-B HLA-C SYNE1 MMP23B B3GNT7 DIP2A	1.13e-06	195	176	8	ed41e709523cc3b86b1090d4fc0938ed47cb1fc9
ToppCell	COVID-19-Heart-EC_1\|Heart / Disease (COVID-19 only), tissue and cell type	HLA-A HLA-B HLA-C MYO10 SYNE1 PRAG1 PTPRB SEC14L1	1.13e-06	195	176	8	50a193475db1bb1e05b8590225a553688c372c14
ToppCell	mild-Myeloid-Neutrophils_4\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	HLA-B HLA-C CR1 IFIT2 CLEC4E CSF3R PLXNC1 SEC14L1	1.17e-06	196	176	8	f8c98cded5550843322b1711e1a57c7e88cae861
ToppCell	LV-09._Endothelium_I\|LV / Chamber and Cluster_Paper	CPAMD8 HLA-A HLA-B HLA-C SYNE1 PRAG1 PTPRB SEC14L1	1.22e-06	197	176	8	f9731d4d636e51b94a96805eee6afe9aedc175e3
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	HLA-A HLA-B HLA-C SYNE1 SPG11 DIP2A CD3E CD96	1.22e-06	197	176	8	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	severe_influenza-NK\|World / disease group, cell group and cell class (v2)	PRSS57 HLA-A HLA-C SYNE1 MMP23B DIP2A CD96 KLHL4	1.22e-06	197	176	8	8e86a1ee0418e153d4f0bf291006cffc6cf36f71
ToppCell	severe_COVID-19-NK\|World / disease group, cell group and cell class (v2)	HLA-A HLA-B HLA-C SYNE1 MMP23B B3GNT7 DIP2A CD96	1.26e-06	198	176	8	36b1370ef68c4bbe0268933a6ef5e6022d992bdf
ToppCell	severe_influenza-NK\|severe_influenza / disease group, cell group and cell class (v2)	PRSS57 HLA-A HLA-C SYNE1 MMP23B CD3E NLRC3 CD96	1.26e-06	198	176	8	d431beb870ff5e165d98febfb27049d729e37dc8
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Hematopoietic\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-B HLA-C CD3E CSF3R C3AR1 SIGLEC1 CD96 FERMT3	1.26e-06	198	176	8	23314bed02edadccdc5da4fa153142a25e4a440e
ToppCell	cellseq2-Immune\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	HLA-A HLA-B HLA-C ANKRD44 CD3E C3AR1 CD96 FERMT3	1.31e-06	199	176	8	631f29931d102ea308088809a05281588c9c9e3d
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-A HLA-B SLC39A8 CLEC4E CSF3R C3AR1 SIGLEC1 FERMT3	1.31e-06	199	176	8	d2783e69da653184e38dc6d85b23521790fa24b8
ToppCell	tumor_Lung-Endothelial_cells-Tip-like_ECs\|Endothelial_cells / Location, Cell class and cell subclass	HLA-A HLA-B HLA-C IFIT2 ANKRD44 CLEC4E PLXNC1 SEC14L1	1.31e-06	199	176	8	80c8641cfd84436eadf2234f1313749e2f73331f
ToppCell	Healthy/Control-NK\|World / Disease group and Cell class	HLA-A HLA-B HLA-C SYNE1 MMP23B B3GNT7 CD3E CD96	1.31e-06	199	176	8	87af9c38938dc2db0f9cf9f3676895d2a8b5d7e6
ToppCell	COVID-19-lung\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HLA-A HLA-B HLA-C SLC39A8 ANKRD44 CSF3R PLXNC1 SIGLEC1	1.31e-06	199	176	8	155b03b859157013e9142e9248551369127d9204
ToppCell	distal\|World / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	HLA-A HLA-B HLA-C CAMP CLEC4E PTPRB C3AR1 FERMT3	1.31e-06	199	176	8	2143b31f54a1a0ec529a91b79f2cb5bb48adabcf
ToppCell	Biopsy_Control_(H.)-Immune-NK_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	PRSS57 HLA-A HLA-B HLA-C MMP23B CD3E NLRC3 CD96	1.36e-06	200	176	8	c93393d52ed1c238d539f254fd2a95eb101a6f65
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-B HLA-C SYNE1 COLEC10 CLEC4E PXDN SERPINE1 SEC14L1	1.36e-06	200	176	8	3767abc75176779198505ebc6967d55ce322d9fe
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-A HLA-B HLA-C COLEC10 CLEC4E PXDN SERPINE1 SEC14L1	1.36e-06	200	176	8	e0a003d2a5fd6adfcb817c9bc5dceb9c79e7491b
ToppCell	Control-Myeloid-Neutrophils-Neutrophils\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CAMP CLEC4E CSF3R PLXNC1 PTX3 C3AR1 FERMT3	2.61e-06	153	176	7	e3630f2b10f33092a3b6a63dba3a39fbdecbc7bd
ToppCell	Control-Myeloid-Neutrophils\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CAMP CLEC4E CSF3R PLXNC1 PTX3 C3AR1 FERMT3	2.61e-06	153	176	7	c33d63b2d1a220bc428e776b157b23faa43ea8ca
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-A HLA-B HLA-C CR1 CLEC4E CSF3R PLXNC1	4.47e-06	166	176	7	6a65dff1333f39ec8c584e6df04b8c1e7f1c8946
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	HLA-A HLA-B SYNE1 BTBD17 DIP2A CD3E CD96	4.84e-06	168	176	7	b94b1f37c92e019d01ecfa3b7cc6797b6e4a56ff
ToppCell	367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	HLA-A HLA-B HLA-C COLEC10 CLEC4E SERPINE1 NOS2	5.03e-06	169	176	7	225aec04ba762d4c55885257de03a65b63503fbb
ToppCell	367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	HLA-A HLA-B HLA-C COLEC10 CLEC4E SERPINE1 NOS2	5.03e-06	169	176	7	278960f940b646a788360b1c84d641a8d169896b
ToppCell	390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	HLA-B HLA-C LRRC4B ZNF850 CLEC4E C3AR1 NOS2	5.23e-06	170	176	7	a6fa0cab1fa829ec601fe48306b4c43c83425b04
ToppCell	390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	HLA-B HLA-C LRRC4B ZNF850 CLEC4E C3AR1 NOS2	5.23e-06	170	176	7	b40255eee45eb18b5a297336d7f3845fd8f8aa3b
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SH3TC2 MROH2B ANKRD61 GNB2 BFSP2 ART5	5.30e-06	111	176	6	bb59f1909645fd512f0ea806e5593d4a1c6e25d9
ToppCell	metastatic_Brain-T/NK_cells-Cytotoxic_CD8+_T\|metastatic_Brain / Location, Cell class and cell subclass	HLA-A HLA-B HLA-C MTMR8 ANKRD44 CD3E NLRC3	5.43e-06	171	176	7	d3e1cc1b70256c4d01488d6b6130bbcae99bdeec
ToppCell	LPS_only-Myeloid-Neutrophils-Neutrophils\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CAMP ANKRD44 CLEC4E CSF3R PLXNC1 PTX3 C3AR1	7.33e-06	179	176	7	d034651a5a355a58f5e15db627869f4feebdfe35
ToppCell	LPS_only-Myeloid-Neutrophils\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CAMP ANKRD44 CLEC4E CSF3R PLXNC1 PTX3 C3AR1	7.33e-06	179	176	7	d0a03e498afcfeb657037889685ecd77bed07e6c
ToppCell	COVID-19-kidney-Mito-rich_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	HLA-B ANKRD44 CLEC4E CD3E CSF3R PLXNC1 CD96	7.88e-06	181	176	7	8448c2ad560cfd48bfe9dc1dd3a64373e6a622dd
ToppCell	LPS_only-Myeloid\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CAMP ANKRD44 CSF3R PLXNC1 PTX3 C3AR1 FERMT3	8.17e-06	182	176	7	666ac86ee5f6fa9241ae8d80340743707e54b278
ToppCell	normal-na-Lymphocytic_T-CytoT_GZMK+-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	HLA-A HLA-B HLA-C SYNE1 CD3E CD96 KLHL4	8.47e-06	183	176	7	79defd22b3194dad16db55b9bdd220c09c1e6b90
ToppCell	LPS-IL1RA-Myeloid\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CAMP CLEC4E CSF3R PLXNC1 PTX3 C3AR1 FERMT3	9.09e-06	185	176	7	9b5fd87ea9d05e051ff1251578ecfbe5e8652853
ToppCell	Control-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	HLA-C SYNE1 CLEC4E PLXNC1 SERPINE1 NOS2 SEC14L1	1.01e-05	188	176	7	88b3415e33db81726dd29c1f50c886e057af50a0
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-A HLA-B CR1 CLEC4E CSF3R TECPR2 PLXNC1	1.08e-05	190	176	7	212f0d9defcc3174e225cc3d90e7814e238794b6
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-A HLA-B HLA-C ANKRD44 CD3E NLRC3 CD96	1.08e-05	190	176	7	81e7d4f97b958b4ed14298a77104ef31a6ec6c91
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-A HLA-B HLA-C ANKRD44 CD3E NLRC3 CD96	1.08e-05	190	176	7	a1b19028c36d192352bc8a7f187790f4b56cfe17
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-A HLA-B HLA-C ANKRD44 CD3E NLRC3 CD96	1.08e-05	190	176	7	423b54c6d48d6981a9522043252239303dccaf04
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-A HLA-B CAMP CR1 CLEC4E CSF3R PLXNC1	1.12e-05	191	176	7	78ede1f15484414a2a54a2f0f0cb6abe0c6b6513
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SYNE1 COLEC10 PXDN STARD9 SERPINE1 NOS2 SEC14L1	1.12e-05	191	176	7	f229abf69a1217194f74b0502486907e07dba989
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	CPAMD8 HLA-C MYO10 SYNE1 PRAG1 PTPRB SEC14L1	1.12e-05	191	176	7	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-A HLA-B CAMP CR1 CLEC4E CSF3R PLXNC1	1.12e-05	191	176	7	d049ab9abd5f8d497eb7e3ccb39b28283298bc65
ToppCell	PSB-critical-LOC-Myeloid-Neutrophil\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CR1 IFIT2 CLEC4E CSF3R PLXNC1 C3AR1 FERMT3	1.16e-05	192	176	7	8dbdaa6a81767a866fb856f99ae35f9ee8064106
ToppCell	COVID-19-kidney-Myeloid\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HLA-B CR1 ANKRD44 CLEC4E CSF3R PLXNC1 C3AR1	1.16e-05	192	176	7	0b9d22a222f1201e375f8e55cace9ef939febae4
ToppCell	URO-Lymphocyte-T_NK-CD8_TEM\|URO / Disease, Lineage and Cell Type	HLA-A HLA-B HLA-C SYNE1 CD3E NLRC3 CD96	1.16e-05	192	176	7	31b6d068f7adc6952c4cf625df851a10cb1b00c9
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	HLA-A HLA-B HLA-C SYNE1 DIP2A CD3E CD96	1.16e-05	192	176	7	fdc741e1846cfd8ed741b160e3c611c310c5d36d
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	HLA-A HLA-B HLA-C SYNE1 DIP2A CD3E CD96	1.20e-05	193	176	7	fce4f805e53669acb4c188f87ac7d84408c0c218
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	HLA-A HLA-B HLA-C SYNE1 DIP2A CD3E CD96	1.20e-05	193	176	7	6e1498153a7766c03fddbda1701dbf1596d21736
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CPAMD8 ARHGAP40 MYO9A SYNE1 PRAG1 STRN ADGRA3	1.20e-05	193	176	7	42df7ed37d11fb542b4d1d714b6f87ae8e1396a6
ToppCell	RV-09._Endothelium_I\|World / Chamber and Cluster_Paper	CPAMD8 HLA-B HLA-C SYNE1 PRAG1 PTPRB SEC14L1	1.20e-05	193	176	7	e3fa47e2c7cd8a5b69186711c57751f2296de8ae
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SYNE1 CAMP CLEC4E DIP2A CSF3R PTX3 NBEAL2	1.20e-05	193	176	7	e1855cff9a6bcfda9188b9fdf6c9d698405da990
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CPAMD8 ARHGAP40 MYO9A SYNE1 PRAG1 STRN ADGRA3	1.20e-05	193	176	7	f42a0f02ed00fe1bb833ff0a0640d9131bca89bd
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-A HLA-B HLA-C COLEC10 PXDN SERPINE1 ART5	1.20e-05	193	176	7	aaf681f16f310168e4719464814a1fc0a2f8431a
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CPAMD8 ARHGEF28 MYO9A SYNE1 PRAG1 STRN ADGRA3	1.24e-05	194	176	7	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	URO-Lymphocyte-T_NK\|URO / Disease, Lineage and Cell Type	HLA-A HLA-B HLA-C SYNE1 CD3E NLRC3 CD96	1.24e-05	194	176	7	4806c07dcf1bc6d9591548382b77817568eb16b6
ToppCell	RV-09._Endothelium_I\|RV / Chamber and Cluster_Paper	CPAMD8 HLA-B HLA-C SYNE1 PRAG1 PTPRB SEC14L1	1.24e-05	194	176	7	7b408096e717f2327c12aea35a8d5fc4621d3b06
ToppCell	3'_v3-blood-Lymphocytic_NK-NK_CD16\|blood / Manually curated celltypes from each tissue	HLA-A HLA-B HLA-C SYNE1 MMP23B B3GNT7 DIP2A	1.28e-05	195	176	7	789149fb52d9d16393e1649358515add60d37f2d
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PRSS57 HLA-A HLA-B HLA-C SYNE1 MMP23B B3GNT7	1.28e-05	195	176	7	acc603dc94ac6518adb0dffb43305b380ec75b52
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A MYO10 SLC30A8 ARFGEF1 TULP4 G6PC2 ATP2A2	1.28e-05	195	176	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	normal-na-Lymphocytic_NK\|normal / PBMC cell types (v2) per disease, treatment status, and sex	PRSS57 HLA-A HLA-B HLA-C SYNE1 MMP23B B3GNT7	1.28e-05	195	176	7	cebe79c42af5910353ba9ad7d0edb01982f772a3
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NLRP1 CR1 ANKRD44 CD3E CSF3R SIGLEC1 CD96	1.28e-05	195	176	7	2d485373bfd9bb4bb9236bf0b31d03e132c8018f
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PRSS57 HLA-A HLA-B HLA-C SYNE1 MMP23B B3GNT7	1.28e-05	195	176	7	72f42f0be53a2a61f61647118b4883e752d998a5
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PRSS57 HLA-A HLA-B HLA-C SYNE1 MMP23B B3GNT7	1.28e-05	195	176	7	49a4f58aac168fc1838bd5d2b202135cd794c28b
ToppCell	3'_v3-blood-Lymphocytic_NK\|blood / Manually curated celltypes from each tissue	HLA-A HLA-B HLA-C SYNE1 MMP23B B3GNT7 DIP2A	1.28e-05	195	176	7	731a454e45c7b610e0140312bcabaea711dcc766
ToppCell	LV-09._Endothelium_I\|World / Chamber and Cluster_Paper	CPAMD8 HLA-B HLA-C SYNE1 PRAG1 PTPRB SEC14L1	1.28e-05	195	176	7	19e0a6c3eae1615aaa39767300acd937dfcb2a7f
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-A HLA-B CLEC4E CSF3R PLXNC1 C3AR1	1.31e-05	130	176	6	793c42602dde22da0715a5304ea70d791fdd5354
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-A HLA-B HLA-C CR1 IFIT2 CSF3R PLXNC1	1.32e-05	196	176	7	fe8d3f45a64323947c36b127355d5940eb56c0ca
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PRSS57 HLA-A HLA-B HLA-C SYNE1 MMP23B B3GNT7	1.32e-05	196	176	7	c25f90c4e5abfe7cfaa85bfe136c438a5179c978
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-A HLA-B HLA-C CR1 IFIT2 CSF3R PLXNC1	1.32e-05	196	176	7	526d037bb12d81f1c235c60ddc787fbad0bbad77
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PRSS57 HLA-A HLA-B HLA-C SYNE1 MMP23B B3GNT7	1.32e-05	196	176	7	d451f279f4086fcf727af712f98923551181c76e
ToppCell	normal-na-Lymphocytic_NK-NK_dim\|normal / PBMC cell types (v2) per disease, treatment status, and sex	PRSS57 HLA-A HLA-B HLA-C SYNE1 MMP23B B3GNT7	1.32e-05	196	176	7	3360d96dc06241498995bcb875615bd4c1424f5a
ToppCell	normal-na-Lymphocytic_NK-NK_dim-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	PRSS57 HLA-A HLA-B HLA-C SYNE1 MMP23B B3GNT7	1.32e-05	196	176	7	61bc0d161e01f36e5bcda4d4f4693afbfe5654bb
ToppCell	5'-Adult-SmallIntestine-Hematopoietic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CLEC4E CSF3R C3AR1 SIGLEC1 MERTK CD96 SEC14L1	1.32e-05	196	176	7	008e7593ab26988b957673f863bdd017516281ae
ToppCell	10x5'-bone_marrow-Lymphocytic_NK-NK_CD16\|bone_marrow / Manually curated celltypes from each tissue	HLA-A HLA-B HLA-C SYNE1 MMP23B B3GNT7 DIP2A	1.32e-05	196	176	7	a3b077e82b1550eb328c84b567b60179001f9a77
ToppCell	10x5'-bone_marrow-Lymphocytic_NK\|bone_marrow / Manually curated celltypes from each tissue	HLA-A HLA-B HLA-C SYNE1 MMP23B B3GNT7 DIP2A	1.32e-05	196	176	7	1868ad537b7f04cdad0a0c8282aadbc4f257a722
ToppCell	cellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD8_T\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	HLA-A HLA-B HLA-C ANKRD44 CD3E NLRC3 CD96	1.37e-05	197	176	7	b6ad0a310f557b97d8192a2389692bf3567800cc
ToppCell	Control-Lymphoid-CD8_T_cells\|Control / Condition, Lineage and Cell class	HLA-A HLA-B HLA-C SYNE1 CD3E NLRC3 CD96	1.37e-05	197	176	7	68d68ec9254f0fb9f1a1f5f98ef0ef736989b308
ToppCell	normal-na-Lymphocytic_NK-natural_killer_cell-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	PRSS57 HLA-A HLA-B HLA-C SYNE1 MMP23B B3GNT7	1.37e-05	197	176	7	994d3289a5dd1a89fbcf28a6263e3784ccf732df
ToppCell	Influenza_Severe-NK\|World / Disease group and Cell class	PRSS57 HLA-A HLA-C SYNE1 MMP23B CD96 KLHL4	1.37e-05	197	176	7	565d578f7a28a19175d56663bf30c60e0d5e1b22
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PRSS57 HLA-A HLA-B HLA-C SYNE1 MMP23B B3GNT7	1.37e-05	197	176	7	76304df40f87224f8e415677e3ee8fb183fe0c03
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANKRD44 CLEC4E CSF3R PLXNC1 C3AR1 SIGLEC1 MERTK	1.37e-05	197	176	7	6ca6e17b7cc5f7ea8d4b6ca1ff670969bee65a45
ToppCell	LA-09._Endothelium_I\|LA / Chamber and Cluster_Paper	CPAMD8 HLA-B HLA-C SYNE1 PRAG1 PTPRB SEC14L1	1.37e-05	197	176	7	ab6d1ab586a188597a39854ef980b8955ebcc645
ToppCell	normal-na-Lymphocytic_NK-natural_killer_cell\|normal / PBMC cell types (v2) per disease, treatment status, and sex	PRSS57 HLA-A HLA-B HLA-C SYNE1 MMP23B B3GNT7	1.37e-05	197	176	7	73a33d8b27043ba3074d04bc2d18cd287e00117f
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH3TC2 BCORL1 IFIT2 CD3E WRAP73 KIF14	1.37e-05	131	176	6	419a0a83b38eaea890d065c3f252ef83c2d37b5b
ToppCell	COVID-19_Moderate-CD8+_Tem\|World / disease group, cell group and cell class	HLA-A HLA-B HLA-C SYNE1 CD3E CD96 KLHL4	1.41e-05	198	176	7	1d12be256af028c88e31fb535068bae16b7bd48e
ToppCell	COVID-19_Severe-Neu_1\|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients	HLA-B HLA-C CR1 IFIT2 CLEC4E CSF3R PLXNC1	1.41e-05	198	176	7	bbe639ea5a636c985e509fb0a133ae3b60afac5a
ToppCell	Healthy-NK\|Healthy / disease group, cell group and cell class	PRSS57 HLA-A HLA-B HLA-C SYNE1 MMP23B DIP2A	1.41e-05	198	176	7	3402f88ef2f05d61c16cbe61b996bcc8fd119261
ToppCell	severe-Myeloid-Neutrophils_2\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	HLA-A HLA-B HLA-C IFIT2 CLEC4E CSF3R SIGLEC1	1.41e-05	198	176	7	636878836678a0715550fa09f2e3dac11c4d73fe
ToppCell	COVID-19-Lymphoid-CD8_T_cells\|COVID-19 / Condition, Lineage and Cell class	HLA-A HLA-B HLA-C SYNE1 CD3E NLRC3 CD96	1.46e-05	199	176	7	8e322d0d097df160554e3024ec9edae4a77a66cc
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-A HLA-B HLA-C SYNE1 MMP23B B3GNT7 DIP2A	1.46e-05	199	176	7	4820f5bcd7bc34c2ebf6a3422cc8eb383a3b5a4e
Computational	Genes in the cancer module 293.	HLA-A HLA-B HLA-C HLA-G	2.07e-06	12	89	4	MODULE_293
Computational	Genes in the cancer module 143.	HLA-A HLA-B HLA-C HLA-G	4.13e-06	14	89	4	MODULE_143
Computational	Neighborhood of INPP5D	HLA-A HLA-B HLA-C HLA-G	4.24e-04	43	89	4	GNF2_INPP5D
Computational	Neighborhood of HLA-C	HLA-A HLA-B HLA-C HLA-G	5.97e-04	47	89	4	GNF2_HLA_C
Computational	Neighborhood of PTPN6	HLA-A HLA-B HLA-C HLA-G	5.97e-04	47	89	4	GNF2_PTPN6
Computational	Genes upregulated in subsets of cells of a given type within various tumors	HLA-A HLA-B HLA-C IFIT2	7.56e-04	50	89	4	GAVISH_3CA_MALIGNANT_METAPROGRAM_17_INTERFERON_MHC_II_1
Drug	4-chloronitrobenzene	APTX NLRP1 CFB CD3E	1.59e-06	12	175	4	CID000007474
Drug	cyclizine	MYO5B CAMP APTX SLC30A8 CFB ANAPC2 HERC2 ATP2A2	3.26e-06	116	175	8	CID000006726
Disease	graft-versus-host disease (implicated_via_orthology)	HLA-A HLA-B HLA-C HLA-G	3.34e-08	7	166	4	DOID:0081267 (implicated_via_orthology)
Disease	Drug-Induced Stevens Johnson Syndrome	HLA-A HLA-B HLA-C NOS2	2.06e-05	29	166	4	C1274933
Disease	Mycoplasma-Induced Stevens-Johnson Syndrome	HLA-A HLA-B HLA-C NOS2	2.06e-05	29	166	4	C3658301
Disease	Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum	HLA-A HLA-B HLA-C NOS2	2.06e-05	29	166	4	C3658302
Disease	Toxic Epidermal Necrolysis	HLA-A HLA-B HLA-C NOS2	2.06e-05	29	166	4	C0014518
Disease	Stevens-Johnson Syndrome	HLA-A HLA-B HLA-C NOS2	2.36e-05	30	166	4	C0038325
Disease	beta-2 microglobulin measurement	HLA-A HLA-B HLA-C	2.79e-05	11	166	3	EFO_0005197
Disease	–	HLA-A HLA-B	3.15e-05	2	166	2	608579
Disease	Susceptibility to severe cutaneous adverse reaction	HLA-A HLA-B	3.15e-05	2	166	2	cv:C1840548
Disease	Carbamazepine response	HLA-A HLA-B	3.15e-05	2	166	2	cv:CN077964
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	HLA-A HLA-B HLA-C HLA-G SPG11 SLC39A8 CYP2W1 MMAA DOCK7	4.28e-05	291	166	9	EFO_0008317, EFO_0020946
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	HLA-A HLA-B HLA-G SPG11 SLC39A8 DNAH1 DOCK7	1.45e-04	200	166	7	EFO_0004611, EFO_0020945
Disease	frontal fibrosing alopecia	CACNA1A NR2C1 HLA-B MYO10	1.55e-04	48	166	4	EFO_0009855
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	HLA-A HLA-B HLA-G SPG11 SLC39A8 DOCK7	1.70e-04	144	166	6	EFO_0004611, EFO_0020943
Disease	Stunned Myocardium	ATP2A2 NOS2	1.87e-04	4	166	2	C0206145
Disease	Myocardial Stunning	ATP2A2 NOS2	1.87e-04	4	166	2	C0206146
Disease	Takayasu Arteritis	HLA-B NOS2	1.87e-04	4	166	2	C0039263
Disease	Hibernation, Myocardial	ATP2A2 NOS2	1.87e-04	4	166	2	C0376416
Disease	Stevens-Johnson syndrome (is_implicated_in)	HLA-A HLA-B	1.87e-04	4	166	2	DOID:0050426 (is_implicated_in)
Disease	phosphatidylcholine 34:3 measurement	MYO1B METTL4 SNX29	2.49e-04	22	166	3	EFO_0010377
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	HLA-A HLA-B HLA-G SPG11 SLC39A8 CYP2W1 DOCK7	2.74e-04	222	166	7	EFO_0008317, EFO_0020943
Disease	allergic asthma (is_implicated_in)	HLA-B HLA-C	3.11e-04	5	166	2	DOID:9415 (is_implicated_in)
Disease	Anterior segment mesenchymal dysgenesis	CPAMD8 PXDN	3.11e-04	5	166	2	C1862839
Disease	Myasthenia Gravis	HLA-B CFB	4.65e-04	6	166	2	C0026896
Disease	Myasthenia Gravis, Ocular	HLA-B CFB	4.65e-04	6	166	2	C0751340
Disease	Myasthenia Gravis, Generalized	HLA-B CFB	4.65e-04	6	166	2	C0751339
Disease	phospholipid measurement, high density lipoprotein cholesterol measurement	HLA-A HLA-B MYO5B SNX29 SLC39A8 CYP2W1 DOCK7 LHFPL5	4.91e-04	321	166	8	EFO_0004612, EFO_0004639
Disease	lymphocyte measurement	HLA-A HLA-B HLA-C SLC39A8 GNB2	5.35e-04	117	166	5	EFO_0803546
Disease	pulmonary hypertension (is_implicated_in)	SERPINE1 ATP2A2 NOS2	6.35e-04	30	166	3	DOID:6432 (is_implicated_in)
Disease	retinopathy of prematurity (is_implicated_in)	HLA-B SERPINE1	6.49e-04	7	166	2	DOID:13025 (is_implicated_in)
Disease	hepatitis C virus infection, cirrhosis of liver	PKD1L1 MERTK	6.49e-04	7	166	2	EFO_0001422, EFO_0003047
Disease	Periventricular Nodular Heterotopia	TMTC3 ERMARD	6.49e-04	7	166	2	C1868720
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	HLA-A HLA-B HLA-G SPG11 SLC39A8 CYP2W1 DOCK7	7.69e-04	264	166	7	EFO_0008317, EFO_0020944
Disease	androsterone sulfate measurement	BIRC6 SULT2A1 MEPCE	8.43e-04	33	166	3	EFO_0021117
Disease	Intestinal Diseases	MYO5B NOS2	8.61e-04	8	166	2	C0021831
Disease	anterior uveitis (is_implicated_in)	HLA-B CFB	8.61e-04	8	166	2	DOID:1407 (is_implicated_in)
Disease	Anterior segment dysgenesis	CPAMD8 PXDN	8.61e-04	8	166	2	cv:C1862839
Disease	choline measurement	HLA-B SLC39A8 CYP2W1 SPATA45 DOCK7	8.62e-04	130	166	5	EFO_0010116
Disease	mitochondrial metabolism disease (implicated_via_orthology)	VARS2 LARS2 LETM1	1.00e-03	35	166	3	DOID:700 (implicated_via_orthology)
Disease	eosinophil percentage of leukocytes	SH3TC2 HLA-A HLA-B HLA-C HLA-G ARHGEF18 COLEC10 SLC39A8 CSF3R PLXNC1 ANAPC2 LHFPL5	1.10e-03	746	166	12	EFO_0007991
Disease	C-reactive protein measurement	ARHGEF28 HLA-B HLA-C SPG11 AGBL5 PRAG1 CIT SLC39A8 CYP2W1 ANKRD44 STRN PXDN DOCK7 MERTK TUBD1 NR1H4	1.33e-03	1206	166	16	EFO_0004458
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	HLA-B HLA-G SPG11 SLC39A8 DOCK7	1.63e-03	150	166	5	EFO_0004611, EFO_0020947
Disease	schizophrenia, gastroesophageal reflux disease	SLC39A8 ATP2A2	1.67e-03	11	166	2	EFO_0003948, MONDO_0005090
Disease	free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	HLA-B HLA-C SPG11 BIRC6 SLC39A8 CYP2W1 DOCK7	1.70e-03	303	166	7	EFO_0004612, EFO_0020945
Disease	basophil count	HLA-A HLA-B HLA-C HLA-G ARHGEF18 CIT SLC39A8 CSF3R TUBD1	1.73e-03	483	166	9	EFO_0005090
Disease	asthma (is_implicated_in)	HLA-B HLA-G SERPINE1 C3AR1 NOS2	1.99e-03	157	166	5	DOID:2841 (is_implicated_in)
Disease	serum gamma-glutamyl transferase measurement	MYO9A NLRP1 MYO1B COLEC10 CIT SLC39A8 CYP2W1 STRN NBEAL2 SIGLEC1 CABIN1 NR1H4 EXOC4	2.06e-03	914	166	13	EFO_0004532
Disease	fatty acid measurement, fetal genotype effect measurement, breast milk measurement	ATP8A2 SNX29	2.36e-03	13	166	2	EFO_0005110, EFO_0007959, EFO_0009092
Disease	1-stearoyl-2-linoleoyl-GPI (18:0/18:2) measurement	MYO5B DOCK7	2.36e-03	13	166	2	EFO_0800413
Disease	neutrophil percentage of leukocytes	HLA-A HLA-B HLA-G ARHGEF18 AARSD1 CFB TMTC3 CSF3R C3AR1 MERTK	2.48e-03	610	166	10	EFO_0007990
Disease	Manganese Poisoning	SLC39A8 NOS2	2.74e-03	14	166	2	C0677050
Disease	fatty acid measurement, breast milk measurement, parental genotype effect measurement	ATP8A2 SNX29	2.74e-03	14	166	2	EFO_0005110, EFO_0005939, EFO_0009092
Disease	Arthritis, Psoriatic	HLA-C NOS2	2.74e-03	14	166	2	C0003872
Disease	diabetic retinopathy (is_implicated_in)	HLA-B CFB SERPINE1	2.82e-03	50	166	3	DOID:8947 (is_implicated_in)
Disease	killer cell immunoglobulin-like receptor 2DS2 measurement	HLA-B HLA-C	3.15e-03	15	166	2	EFO_0801746
Disease	complement C4 measurement	HLA-B HLA-C HLA-G	3.16e-03	52	166	3	EFO_0004984
Disease	total phospholipids in lipoprotein particles measurement	HLA-B CYP2W1 DOCK7	3.33e-03	53	166	3	EFO_0022315
Disease	Cholestasis	MYO5B SERPINE1 NOS2 NR1H4	3.51e-03	110	166	4	C0008370
Disease	Hepatomegaly	MYO1B NOS2 NR1H4	3.51e-03	54	166	3	C0019209
Disease	cutaneous psoriasis measurement, psoriasis	HLA-B NOS2	3.58e-03	16	166	2	EFO_0000676, EFO_0007773
Disease	Malaria, susceptibility to	CR1 NOS2	3.58e-03	16	166	2	cv:C1970028
Disease	–	CR1 NOS2	3.58e-03	16	166	2	611162
Disease	acute lymphoblastic leukemia (is_implicated_in)	CREBBP CFB GNB1	3.70e-03	55	166	3	DOID:9952 (is_implicated_in)
Disease	Intellectual Disability	CNKSR1 ATP8A2 SYNE1 TRRAP LETM1 PGAP2 SERAC1 GNB1	3.93e-03	447	166	8	C3714756
Disease	anti-anoctamin 2 antibody measurement	HLA-C CFB	4.05e-03	17	166	2	EFO_0010150
Disease	keratinocyte carcinoma	HLA-B COLEC10 STRN HERC2	4.51e-03	118	166	4	EFO_0010176
Disease	Atherosclerosis	SERPINE1 NOS2 NR1H4	4.51e-03	59	166	3	C0004153
Disease	Atherogenesis	SERPINE1 NOS2 NR1H4	4.51e-03	59	166	3	C1563937
Disease	asthma (biomarker_via_orthology)	SERPINE1 C3AR1 NOS2	4.51e-03	59	166	3	DOID:2841 (biomarker_via_orthology)
Disease	glycoprotein measurement	HLA-A HLA-B PRAG1 DOCK7	4.65e-03	119	166	4	EFO_0004555
Disease	cytokine measurement	HLA-A HLA-B HLA-C ATP8A2 HLA-G MROH5 FOCAD PRRC1	4.72e-03	461	166	8	EFO_0004873
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	HLA-A HLA-B SPG11 SLC39A8	4.93e-03	121	166	4	EFO_0008595, EFO_0020943
Disease	psoriasis vulgaris	HLA-B HLA-C NOS2	4.96e-03	61	166	3	EFO_1001494
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	HLA-B SPG11 DOCK7	4.96e-03	61	166	3	EFO_0008317, EFO_0008596, EFO_0020946
Disease	cystic fibrosis (is_marker_for)	HLA-G CSF3R NOS2	5.19e-03	62	166	3	DOID:1485 (is_marker_for)
Disease	Malaria	CR1 NOS2	5.59e-03	20	166	2	C0024530

Protein segments in the cluster

Peptide	Gene	Start	Entry
SEHSSLTNLRAWMLK	AGBL5	581	Q8NDL9
LTNLRAWMLKHVRNS	AGBL5	586	Q8NDL9
AWMLKHVRNSRGLSS	AGBL5	591	Q8NDL9
SATGEAWHNIMLSCL	CACNA1A	1751	O00555
LQRQLHLEGMLCWKT	ARHGEF18	681	Q6ZSZ5
HLEGMLCWKTTSGRL	ARHGEF18	686	Q6ZSZ5
AMRTLSWKHTLGLVT	ANAPC2	631	Q9UJX6
LRTWCLVLHSLTLMT	BIRC6	2716	Q9NR09
SSIRVSRKGWHMLLN	ADGRA2	796	Q96PE1
SLIRISLKSWHMLVN	ADGRA3	786	Q8IWK6
WLCAVSMDELLSTTH	ARFGEF1	1146	Q9Y6D6
WAMLTLVGLVTHAAQ	BTBD17	16	A6NE02
VHNWTSSDRIRMCGI	BCORL1	11	Q5H9F3
ESLGHWSQGLKISMQ	APTX	176	Q7Z2E3
WSTLCMLVELHTQGQ	CREBBP	1686	Q92793
TSATLQWAALLMGRH	CYP2W1	301	Q8TAV3
LSGNRVLKWMERSHG	AARSD1	241	Q9BTE6
MLSSGRWNDTECHLT	COLEC10	251	Q9Y6Z7
LARHGTDLWIDNMSS	ARFGAP2	126	Q8N6H7
DTTGLTTLNLMLLHW	ANKRD61	106	A6NGH8
HNTKGRTWSLMLVSL	MT-ATP6	61	P00846
LRMHLESKATRSGNW	BFSP2	136	Q13515
KTLMSWDHVCIALAS	C3AR1	411	Q16581
SSSLHLEGWMKVPRN	CIT	1441	O14578
QATMVLSSAHFWLGL	ATP8A2	1061	Q9NTI2
SASRLLFLSMHWALS	NR2C1	396	P13056
MWAHNGEVRTARLLS	PCDHB5	616	Q9Y5E4
GQVALRTSLELWMHT	NCSTN	366	Q92542
MSWRVNDHKFTPLLC	NR1H4	466	Q96RI1
LGNRKLLWHGTNMAV	PARP3	376	Q9Y6F1
GSSHQIWHILAVVML	PAQR3	271	Q6TCH7
SHRESLLHLAMRWGL	ARHGEF28	161	Q8N1W1
LLHLAMRWGLAKLSQ	ARHGEF28	166	Q8N1W1
ESQSLSLCGMVWEHR	CFB	471	P00751
ALWTGMHTIAAQLLG	ANKFY1	596	Q9P2R3
ALTLTETWAGSHSMR	HLA-G	16	P17693
GRRMGLETHKLASLW	NOS2	396	P35228
GNLGMTTLIWLSSHL	OR8G1	41	Q15617
ASSLGHMLLTCILWR	PGAP2	151	Q9UHJ9
RSTITHLLGNWKAIM	ESPNL	801	Q6ZVH7
MKHWLSDLLPCTNIA	KIF14	1321	Q15058
MLSHGAGLALWITLS	PTPRB	1	P23467
GTLTQAATMGHWILL	MDN1	386	Q9NU22
RHTAGMLALSWALAL	GPR88	156	Q9GZN0
FCRLTGMALGHLWRS	NLRC3	331	Q7RTR2
HLTLSIACKWGPSRM	MEPCE	456	Q7L2J0
TWKSTEHNMGLALTR	MGAT2	311	Q10469
MAWSSLLLTLLAHCT	IGLV1-50	1	A0A075B6I6
RLVRNGVSWSHSSML	MERTK	961	Q12866
SSGWLRHIKAIMDAG	MTMR8	306	Q96EF0
WSHSNGSALVRMALI	MTMR10	286	Q9NXD2
AQLSALAASHRMWAL	HERC2	3761	O95714
GHCTIRWAFMLAILS	LHFPL5	171	Q8TAF8
KIAARMLWRILNGHS	LETM1	176	O95202
GSVSCKDMHLLLWLQ	HMGN2P46	16	Q86SG4
GLALTETWACSHSMR	HLA-C	16	P10321
TTIAMWLCKHLNSSL	AK8	71	Q96MA6
LLTNWMSVCLSGFLR	PLXNC1	1136	O60486
SLFGNSLMILLIHWD	OR2T8	36	A6NH00
AWNLSLIALIKMDSH	OR5A2	41	Q8NGI9
LHTWEQMGLRSLCAQ	NLRP1	71	Q9C000
NSDSLWKPHCMTVRA	FBXO48	71	Q5FWF7
EMHHWITLLQRSKGD	MYO10	1371	Q9HD67
MAWTVLLLGLLSHCT	IGLV3-21	1	P80748
SLGLHCTKWMLLSDG	MMAA	46	Q8IVH4
MHWGTDSRLLVSASQ	GNB2	61	P62879
ALALMGNSWLTHLSL	NLRP5	1001	P59047
RGHATWLSELLQMAL	ANKRD44	746	Q8N8A2
QACLQMAISWHLSRR	ALOX12	586	P18054
SLFGNSLMILLIHWD	OR2T33	36	Q8NG76
HWLGATECVLLATMS	OR2C3	106	Q8N628
ALALTETWAGSHSMR	HLA-B	16	P01889
LRTNSWLHIGTMNGR	KLHL4	451	Q9C0H6
SASWIMNALHSLLHT	OR1G1	146	P47890
WKVLDTLMCQQAHGL	ACP4	206	Q9BZG2
VLGTMLLASKVWRNH	CCNYL3	121	P0C7X3
SSGRTSFSHWLRLKM	DNAH1	2121	Q9P2D7
ANMHESLEWLASRTK	EXOC4	711	Q96A65
WLVGSICLSMSLHFL	ATP2A2	931	P16615
QSTEIKMSLHSGLWR	CACNG5	46	Q9UF02
KMSLHSGLWRVCFLA	CACNG5	51	Q9UF02
SHWLMLCKDVLAASS	HEATR5B	1186	Q9P2D3
VRRAWHGMATLLNKL	KLHL22	481	Q53GT1
GSFAWHMNRSIVLLL	CABIN1	1596	Q9Y6J0
WSLRQLDAGAQHSTM	CCDC138	431	Q96M89
LRLTWLQNMAGKHSE	DOCK7	1686	Q96N67
MQHVSTWLRGSLEGL	CCDC175	741	P0C221
SVSHCVLVGMRSLWN	CR1	1296	P17927
SHCVLAGMKALWNSS	CR1	1751	P17927
SWTHDSLFLACMLKR	CPLANE1	321	Q9H799
MHWGTDSRLLVSASQ	GNB1	61	P62873
MLEVCTRWLHAGSSN	CPAMD8	1556	Q8IZJ3
TRWLHAGSSNMAVLE	CPAMD8	1561	Q8IZJ3
LLHMLISSSSLGGWE	GPR148	101	Q8TDV2
MQSGTHWRVLGLCLL	CD3E	1	P07766
CGMDKFSITLHRLTW	G6PC2	136	Q9NQR9
MKTQRDGHSLGRWSL	CAMP	1	P49913
MARLGNCSLTWAALI	CSF3R	1	Q99062
ALALTQTWAGSHSMR	HLA-A	16	P04439
SSLRQLKCHFTWNLM	IFIT2	11	P09913
TMTNGAHRWSKLRNI	KNDC1	1661	Q76NI1
WNETINLTHTALLKM	ERMARD	641	Q5T6L9
RLTESGLSMVDWHLI	COX15	91	Q7KZN9
VKSRDMHWSLLAQRG	DIP2A	606	Q14689
MHWSLLAQRGQRDVS	DIP2A	611	Q14689
WRCVSILRNHSGDVM	HIRA	121	P54198
AAMRETALWCTGHIR	FAM27E3	51	Q08E93
LLAMWGLVHSNLTCS	B3GNT7	381	Q8NFL0
LTVLTGHSLMSWLVC	RNASE11	181	Q8TAA1
SWTCLVDLEGLNMRH	SEC14L1	391	Q92503
QHWLTESARLISHMG	POLRMT	1051	O00411
EAHTALSRLRASMWI	PKD1L1	2451	Q8TDX9
LAALSHLHRFLLSMW	PKD1L1	2661	Q8TDX9
MSVVHQLSAGWLLDH	METTL4	1	Q8N3J2
SHANTGVLKRMEWLL	FOCAD	1631	Q5VW36
GLTSLRKLWLMHAQV	LRRC4B	251	Q9NT99
IMTHRVCNSLALGTW	OR10G6	156	Q8NH81
MTLHATRGAALLSWV	NUMA1	1	Q14980
LVAEAMVSLGRWTHL	PTX3	256	P26022
ILSAQLISHWKGNMT	SERPINE1	276	P05121
MSRDHCIGLTVAAWL	OR4D10	136	Q8NGI6
LSARHFLWTCLMTRS	MROH5	1216	Q6ZUA9
MTNHLTTWLATCLSI	TAS2R42	91	Q7RTR8
TMTSLCGDWLQGLHR	VARS2	421	Q5ST30
MHLLKVGTWRNNTAS	RNF133	1	Q8WVZ7
LMSGSHDCSIRLWNL	STRN	721	O43815
LHSSIVRSGWVSIMA	SERAC1	331	Q96JX3
NHMDSDKLSGLWSRI	TOR1AIP2	436	Q8NFQ8
TCLSQMHSWAPLKVL	SNX29	381	Q8TEQ0
MSKTNGLSEDLIWHC	SMARCAD1	431	Q9H4L7
DKNMSSLRTWLAHIE	SYNE1	7891	Q8NF91
HMRKQLDRLGLCFSW	LARS2	156	Q15031
AHLRVCMWLGNVTDS	FER1L5	756	A0AVI2
RALMHLNATLRGWKA	MMP23B	226	O75900
SRDTTCMVWRLLHQG	NBEAL2	2521	Q6ZNJ1
DVCNSSWKGHLTLTM	PRSS57	186	Q6UWY2
SWKGHLTLTMLCTRS	PRSS57	191	Q6UWY2
DHRCKWLPASMNTVS	SIAE	446	Q9HAT2
AVAMANLGHLSLKSW	SH3TC2	876	Q8TF17
MNGHVCSQLVLASWL	OR6T1	136	Q8NGN1
EKSLLNVSRTDWHMA	PRRC1	401	Q96M27
LCWHLSGDSMALLSK	WRAP73	421	Q9P2S5
GTNWLAEILCLMHSK	SULT2A1	46	Q06520
LASWTSMHNLSLHLS	STARD9	3671	Q9P2P6
CSLARSMAVWQHGVI	MROH2B	1246	Q7Z745
SDLSAAEMLTLHNWL	CYB5D2	106	Q8WUJ1
MCSHSDGSLTLWNLK	STXBP5L	266	Q9Y2K9
TLMCDESGSRWTLHL	ABHD17B	36	Q5VST6
WALSLKNCSAMGAHL	CLEC4E	101	Q9ULY5
TLTDLSMWVRHLITC	CNKSR1	486	Q969H4
WGLHSNISGMKERLS	C17orf64	171	Q86WR6
GRSSWIKLSLLAHME	SPATA45	71	Q537H7
WSSMEERHLLLTLAG	SPG11	1766	Q96JI7
TWAGLLKHLRQMLIS	TUBD1	291	Q9UJT1
ISICWGHRDSRLLMA	TULP4	346	Q9NRJ4
GVLSVHSLHIWSLTM	SLC30A8	296	Q8IWU4
QLCDAGLKTWLRRMH	ARHGAP40	491	Q5TG30
ENGSKWTLHLRNMSC	CD96	96	P40200
WTLHLRNMSCSVSGR	CD96	101	P40200
WLRHMAAAGISSTIT	SAGE1	651	Q9NXZ1
WSMQTGRLLDVLSGH	PWP2	486	Q15269
RSEKWNHTLSMALIL	TMEM39A	441	Q9NV64
ARHASLMKRWSQLLA	SPTAN1	2056	Q13813
QLGLTSMHTLWFREH	PXDN	981	Q92626
RSHQSRPAKCLTIMW	TMEM214	246	Q6NUQ4
LAHKDAIQLWRTLMG	NME6	86	O75414
HSRWLDSSRCLMQQG	FERMT3	226	Q86UX7
FIRTLSKSCPTGMHW	TECPR2	1191	O15040
SKSCPTGMHWTRLDL	TECPR2	1196	O15040
TGMHWTRLDLSQLGA	TECPR2	1201	O15040
MSWQDHGRILRCQLS	SIGLEC1	206	Q9BZZ2
NALGRMWESRSHTLA	SPTB	1151	P11277
ALCGTLHNWIDMKRA	PRAG1	1346	Q86YV5
SCQTLALPMTIRHSW	nan	676	Q3C1V9
NLCSLMWHTLSHLGI	ZBTB39	491	O15060
VDMWQTRLSTHLGKA	TMEM65	196	Q6PI78
WSAHMAISRPLKASQ	USP37	606	Q86T82
GCGWNFTSMSKLLRH	ZXDA	456	P98168
GKLFMWSSTLITHQR	ZNF547	246	Q8IVP9
SLAEIHSNMWVRNGL	UBR3	676	Q6ZT12
GTIAWMITLCDALHN	SLC39A8	301	Q9C0K1
TLRLWDSRGLQVAHM	WDR31	211	Q8NA23
SWICLSMVILTHSLK	TMTC3	406	Q6ZXV5
DISVALNTRKLWSMH	VIRMA	1136	Q69YN4
TRGHDWRMLAHKLNL	UNC5C	861	O95185
LGKTHNLWFRSTLML	TRRAP	2696	Q9Y4A5
SQWVRMEKCHSLVGS	ZNF850	101	A8MQ14
IKLTMHNWSSTLRED	ZNF891	141	A8MT65
RDLSQAMWKASHALI	MYO1B	536	O43795
LMIALGSLGLHTWQA	ART5	6	Q96L15
NLLLRKDVCSWSTGM	MYO5B	1696	Q9ULV0
RSVKISNVALDSMHW	MYO9A	1836	B2RTY4
SSWRLGLRKTGSHNM	PPP1R12B	436	O60237